<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Br. J. Pharmacol</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1476-5381</journal-id><journal-id journal-id-type="publisher-id">BPH</journal-id><journal-title-group><journal-title>British Journal of Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0007-1188</issn><issn pub-type="epub">1476-5381</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7405496</article-id><article-id pub-id-type="doi">10.1111/bph.15207</article-id><article-id pub-id-type="publisher-id">BPH15207</article-id><article-id pub-id-type="other">2020-BJP-0741-MR.R2</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Review Articles</subject></subj-group></article-categories><title-group><article-title>Sex&#x02010;related differences in COVID&#x02010;19 lethality</article-title><alt-title alt-title-type="left-running-head">Penna et al.</alt-title></title-group><contrib-group><contrib id="bph15207-cr-0001" contrib-type="author"><name><surname>Penna</surname><given-names>Claudia</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9696-0449</contrib-id><xref ref-type="aff" rid="bph15207-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bph15207-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="bph15207-cr-0002" contrib-type="author"><name><surname>Mercurio</surname><given-names>Valentina</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9448-2762</contrib-id><xref ref-type="aff" rid="bph15207-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="bph15207-cr-0003" contrib-type="author" corresp="yes"><name><surname>Tocchetti</surname><given-names>Carlo G.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5983-688X</contrib-id><xref ref-type="aff" rid="bph15207-aff-0003">
<sup>3</sup>
</xref><xref ref-type="aff" rid="bph15207-aff-0004">
<sup>4</sup>
</xref><address><email>carlogabriele.tocchetti@unina.it</email></address></contrib><contrib id="bph15207-cr-0004" contrib-type="author" corresp="yes"><name><surname>Pagliaro</surname><given-names>Pasquale</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4386-1383</contrib-id><xref ref-type="aff" rid="bph15207-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bph15207-aff-0002">
<sup>2</sup>
</xref><address><email>pasquale.pagliaro@unito.it</email></address></contrib></contrib-group><aff id="bph15207-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Clinical and Biological Sciences</named-content>
<institution>University of Torino</institution>
<city>Turin</city>
<country country="IT">Italy</country>
</aff><aff id="bph15207-aff-0002" content-type="private-address">
<label><sup>2</sup></label>
<institution>National Institute of Cardiovascular Researches</institution>
<city>Bologna</city>
<country country="IT">Italy</country>
</aff><aff id="bph15207-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Translational Medical Sciences</named-content>
<institution>Federico II University</institution>
<city>Naples</city>
<country country="IT">Italy</country>
</aff><aff id="bph15207-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Interdepartmental Center of Clinical and Translational Research</named-content>
<institution>Federico II University</institution>
<city>Naples</city>
<country country="IT">Italy</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Prof. Pasquale Pagliaro, Department of Clinical and Biological Sciences, University of Torino, Italy.<break/>
Email: <email>pasquale.pagliaro@unito.it</email><break/>
Carlo Gabriele Tocchetti, Cardio&#x02010;Oncology Unit, Department of Translational Medical Sciences, Interdepartmental Center of Clinical and Translational Research (CIRCET), Federico II University, Via Pansini 5, 80131 Napoli, Italy.<break/>
Email: <email>carlogabriele.tocchetti@unina.it</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2020</year></pub-date><volume>177</volume><issue>19</issue><issue-id pub-id-type="doi">10.1111/bph.v177.19</issue-id><fpage>4375</fpage><lpage>4385</lpage><history><date date-type="received"><day>22</day><month>5</month><year>2020</year></date><date date-type="rev-recd"><day>30</day><month>6</month><year>2020</year></date><date date-type="accepted"><day>10</day><month>7</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 The British Pharmacological Society <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 The British Pharmacological Society</copyright-statement></permissions><self-uri content-type="pdf" xlink:href="file:BPH-177-4375.pdf"/><abstract><p>Many countries have been affected by the worldwide outbreak of COVID&#x02010;19. Among Western countries, Italy has been particularly hit at the beginning of the pandemic, immediately after China. In Italy and elsewhere, women seem to be less affected than men by severe/fatal COVID&#x02010;19 infection, regardless of their age. Although women and men are affected differently by this infection, very few studies consider different therapeutic approaches for the two sexes. Understanding the mechanisms underlying these differences may help to find appropriate and sex specific therapies. Here, we consider that other mechanisms are involved to explain this difference, in addition to the protection attributable to oestrogens. Several X&#x02010;linked genes (such as ACE2) and Y&#x02010;linked genes (SRY and SOX9) may explain sex differences. Cardiovascular comorbidities are among the major enhancers of virus lethality. In addition, the number of sex&#x02010;independent, non&#x02010;genetic factors that can change susceptibility and mortality is enormous, and many other factors should be considered, including gender and cultural habits in different countries.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="bph15207-kwd-0001">cardiovascular comorbidities</kwd><kwd id="bph15207-kwd-0002">coronavirus</kwd><kwd id="bph15207-kwd-0003">ACE</kwd><kwd id="bph15207-kwd-0004">ACE2</kwd><kwd id="bph15207-kwd-0005">androgens</kwd><kwd id="bph15207-kwd-0006">oestrogens</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>SIC/MSD</funding-source></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>MIUR </institution><institution-id institution-id-type="open-funder-registry">10.13039/501100003407</institution-id></institution-wrap></funding-source><award-id>PENC_FFABR_17_01</award-id><award-id>PAGP_FFABR_17_01</award-id></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>University of Torino </institution><institution-id institution-id-type="open-funder-registry">10.13039/100015918</institution-id></institution-wrap></funding-source><award-id>PAGP_RILO_16_01</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="2"/><page-count count="11"/><word-count count="10631"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>October 2020</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.0 mode:remove_FC converted:11.09.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="bph15207-cit-9001">
<string-name>
<surname>Penna</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mercurio</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Tocchetti</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Pagliaro</surname>
<given-names>P</given-names>
</string-name>. <article-title>Sex&#x02010;related differences in COVID&#x02010;19 lethality</article-title>. <source xml:lang="en">Br J Pharmacol</source>. <year>2020</year>;<volume>177</volume>:<fpage>4375</fpage>&#x02013;<lpage>4385</lpage>. <pub-id pub-id-type="doi">10.1111/bph.15207</pub-id>
</mixed-citation>
</p></notes></front><body id="bph15207-body-0001"><def-list list-content="abbreviations" id="bph15207-lp-0001"><title>Abbreviations</title><def-item><term id="bph15207-li-0001">Ang II</term><def id="bph15207-li-0002"><p>angiotensin II</p></def></def-item><def-item><term id="bph15207-li-0003">CAR&#x02010;T</term><def id="bph15207-li-0004"><p>chimeric antigen receptor T&#x02010;cells</p></def></def-item><def-item><term id="bph15207-li-0005">COVID&#x02010;19</term><def id="bph15207-li-0006"><p>coronavirus disease 2019</p></def></def-item><def-item><term id="bph15207-li-0007">CRS</term><def id="bph15207-li-0008"><p>cytokine release syndrome</p></def></def-item><def-item><term id="bph15207-li-0009">CVD</term><def id="bph15207-li-0010"><p>cardiovascular disease</p></def></def-item><def-item><term id="bph15207-li-0011">DEGs</term><def id="bph15207-li-0012"><p>differentially expressed genes</p></def></def-item><def-item><term id="bph15207-li-0013">HF</term><def id="bph15207-li-0014"><p>heart failure</p></def></def-item><def-item><term id="bph15207-li-0015">ICUs</term><def id="bph15207-li-0016"><p>intensive care units</p></def></def-item><def-item><term id="bph15207-li-0017">IKK</term><def id="bph15207-li-0018"><p>I&#x003ba;B kinase</p></def></def-item><def-item><term id="bph15207-li-0019">MEK</term><def id="bph15207-li-0020"><p>MAPK kinase</p></def></def-item><def-item><term id="bph15207-li-0021">mTOR</term><def id="bph15207-li-0022"><p>mammalian target of rapamycin</p></def></def-item><def-item><term id="bph15207-li-0023">RAS</term><def id="bph15207-li-0024"><p>renin angiotensin system</p></def></def-item><def-item><term id="bph15207-li-0025">TMPRSS2</term><def id="bph15207-li-0026"><p>transmembrane protease, serine 2</p></def></def-item></def-list><sec id="bph15207-sec-0001"><label>1</label><title>INTRODUCTION</title><p>The outbreak of novel coronavirus disease 2019 (COVID&#x02010;19) is likely to have started in China (Zhou, Yang, et al.,&#x000a0;<xref rid="bph15207-bib-0091" ref-type="ref">2020</xref>) and rapidly turned into a global pandemic with Europe, the United States, and South America being particularly affected (<ext-link ext-link-type="uri" xlink:href="https://coronavirus.jhu.edu/map.html">https://coronavirus.jhu.edu/map.html</ext-link>, accessed on June 28, 2020). Sex differences are emerging in terms of <italic>case fatality</italic> (deaths/reported cases), and sex disaggregated data are now starting to be available for many countries. Looking at male/female ratio for death in confirmed cases, it appears that the ratio is always above 1.1 in 34 out of the 35 countries that provide sex disaggregated data (only for Pakistan, the ratio is 0.9). Many European countries (Spain, Italy, England, Belgium, Greece, Denmark, and The Netherlands) have a male/female ratio for death in confirmed cases equal or above 1.7 (<ext-link ext-link-type="uri" xlink:href="https://globalhealth5050.org/covid19/">https://globalhealth5050.org/covid19/</ext-link>, accessed on May 13, 2020). In particular, on May 11, 28,903 COVID&#x02010;19 positive patients had died in Italy (Table&#x000a0;<xref rid="bph15207-tbl-0001" ref-type="table">1</xref>). Their mean age was 80 years (median, 81; range, 0&#x02013;100; IQR, 74&#x02013;87; <ext-link ext-link-type="uri" xlink:href="https://www.iss.it/coronavirus">https://www.iss.it/coronavirus</ext-link>, accessed on May 13, 2020). Deaths in women were 10,934 (lethality 9.6%), whereas for men there were 17,018 deatha (lethality 17.1%). For 951 Italian deaths, sex was not reported. At the moment of the revision of this article, this trend is confirmed in the majority of countries which provide disaggregated data (<ext-link ext-link-type="uri" xlink:href="https://globalhealth5050.org/covid19/sex-disaggregated-data-tracker/">https://globalhealth5050.org/covid19/sex-disaggregated-data-tracker/</ext-link>, accessed on June 28, 2020). In 47 countries, the male/female ratio for death results above 1, and in four countries (Albania, Costa Rica, Thailand, and The Netherlands), this ratio is even above 2. Only in five countries (Finland, Maldives, Pakistan, Slovenia, and Yemen), the male/female ratio for death is below 1, ranging from 0.94 to 0.55 (<ext-link ext-link-type="uri" xlink:href="https://globalhealth5050.org/covid19/sex-disaggregated-data-tracker/">https://globalhealth5050.org/covid19/sex-disaggregated-data-tracker/</ext-link>, accessed on June 28, 2020). In the vast majority of countries, the mortality rate among confirmed cases is lower in women than in men. The difference in lethality between sexes may suggest that women are either less prone to develop severe complications or that they are less likely to succumb to the severe complications that ultimately lead to death. The reasons for this sex&#x02010;based tolerance are still unknown. Among Italian patients in the age range 10&#x02013;49 years, only 84 out of 32,345 women died (0.26% lethality), while in the range age of 50&#x02013;90 years, they were 7975/67,263 (11.9% lethality). Of note, 0.89% of men died (225 deaths over 25,276 cases) in the range 10&#x02013;49 years, and 21.8% (15,236/69844) in the range 50&#x02013;90 years. Therefore, lethality seems to increase with age in both sexes, but it is 3.42&#x02010;fold higher in young men than in young women (10&#x02013;49 years) and 1.84&#x02010;fold in older men than in older women (50&#x02013;90 years; <ext-link ext-link-type="uri" xlink:href="https://www.iss.it/coronavirus">https://www.iss.it/coronavirus</ext-link>, accessed on May 13, 2020). This trend in Italian patients is confirmed in data disaggregated by age and sex (<ext-link ext-link-type="uri" xlink:href="https://globalhealth5050.org/covid19/age-and-sex-data/#1589893973981-6ca5e520-eb20">https://globalhealth5050.org/covid19/age&#x02010;and&#x02010;sex&#x02010;data/#1589893973981&#x02010;6ca5e520&#x02010;eb20</ext-link>, accessed on June 28, 2020).</p><table-wrap id="bph15207-tbl-0001" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 1</label><caption><p>Cases and fatality of severe Covid 19 in men and women in Italy and China</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">Number of patients/Covid+ patients</th><th align="left" valign="bottom" rowspan="1" colspan="1">ICU/severe cases</th><th align="left" valign="bottom" rowspan="1" colspan="1">Deceased</th><th align="left" valign="bottom" rowspan="1" colspan="1">Median age of severe/deceased patients</th><th align="left" valign="bottom" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Total Covid+</td><td align="char" valign="top" rowspan="1" colspan="1">131,751</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">14,860</td><td align="char" valign="top" rowspan="1" colspan="1">80</td><td rowspan="3" align="left" valign="top" colspan="1">
<ext-link ext-link-type="uri" xlink:href="https://www.iss.it/coronavirus">https://www.iss.it/coronavirus</ext-link>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Men</td><td align="char" valign="top" rowspan="1" colspan="1">69,960 (53.1%)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">10,062 (67.7%)</td><td align="char" valign="top" rowspan="1" colspan="1">78</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Women</td><td align="char" valign="top" rowspan="1" colspan="1">61,791 (46.9%)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">4,798 (32.3%)</td><td align="char" valign="top" rowspan="1" colspan="1">82</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total of patients</td><td align="char" valign="top" rowspan="1" colspan="1">1,096</td><td align="left" valign="top" rowspan="1" colspan="1">173</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">52</td><td rowspan="3" align="left" valign="top" colspan="1">Guan et al.&#x000a0;(<xref rid="bph15207-bib-0031" ref-type="ref">2020</xref>)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Men</td><td align="char" valign="top" rowspan="1" colspan="1">637(58.1%)</td><td align="left" valign="top" rowspan="1" colspan="1">100 (57.8%)</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Women</td><td align="char" valign="top" rowspan="1" colspan="1">459 (41.9%)</td><td align="left" valign="top" rowspan="1" colspan="1">73 (42.2%)</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total of patients</td><td align="char" valign="top" rowspan="1" colspan="1">191</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">54</td><td align="char" valign="top" rowspan="1" colspan="1">69</td><td rowspan="3" align="left" valign="top" colspan="1">Zhou, Yu, et al.&#x000a0;(<xref rid="bph15207-bib-0089" ref-type="ref">2020</xref>)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Men</td><td align="char" valign="top" rowspan="1" colspan="1">119 (62%)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">38 (70%)</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Women</td><td align="char" valign="top" rowspan="1" colspan="1">72 (38%)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">16 (30%)</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total of patients</td><td align="char" valign="top" rowspan="1" colspan="1">99</td><td align="left" valign="top" rowspan="1" colspan="1">23 (23%)</td><td align="char" valign="top" rowspan="1" colspan="1">11 (11%)</td><td align="char" valign="top" rowspan="1" colspan="1">55.5</td><td rowspan="3" align="left" valign="top" colspan="1">Chen, Zhou, et al.&#x000a0;(<xref rid="bph15207-bib-0013" ref-type="ref">2020</xref>)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Men</td><td align="char" valign="top" rowspan="1" colspan="1">67 (68%)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Women</td><td align="char" valign="top" rowspan="1" colspan="1">32 (32%)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total of patients</td><td align="char" valign="top" rowspan="1" colspan="1">138</td><td align="left" valign="top" rowspan="1" colspan="1">36</td><td align="char" valign="top" rowspan="1" colspan="1">6 (4.3%)</td><td align="char" valign="top" rowspan="1" colspan="1">56</td><td rowspan="3" align="left" valign="top" colspan="1">Wang et al.&#x000a0;(<xref rid="bph15207-bib-0081" ref-type="ref">2020</xref>)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Men</td><td align="char" valign="top" rowspan="1" colspan="1">75 (54%)</td><td align="left" valign="top" rowspan="1" colspan="1">22 (64.1%)</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Women</td><td align="char" valign="top" rowspan="1" colspan="1">63 (45.7%)</td><td align="left" valign="top" rowspan="1" colspan="1">14 (38.9%)</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total of patients</td><td align="char" valign="top" rowspan="1" colspan="1">41</td><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="char" valign="top" rowspan="1" colspan="1">6 (15%)</td><td align="char" valign="top" rowspan="1" colspan="1">49</td><td rowspan="3" align="left" valign="top" colspan="1">Huang et al.&#x000a0;(<xref rid="bph15207-bib-0041" ref-type="ref">2020</xref>)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Men</td><td align="char" valign="top" rowspan="1" colspan="1">30 (73%)</td><td align="left" valign="top" rowspan="1" colspan="1">11 (85%)</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Women</td><td align="char" valign="top" rowspan="1" colspan="1">11 (27%)</td><td align="left" valign="top" rowspan="1" colspan="1">2 (15%)</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td><td align="char" valign="top" rowspan="1" colspan="1">&#x02010;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total of patients</td><td align="char" valign="top" rowspan="1" colspan="1">274</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1">113</td><td align="char" valign="top" rowspan="1" colspan="1">68</td><td rowspan="3" align="left" valign="top" colspan="1">Chen, Wu, et al.&#x000a0;(<xref rid="bph15207-bib-0014" ref-type="ref">2020</xref>)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Men</td><td align="char" valign="top" rowspan="1" colspan="1">171 (62%)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1">83 (73%)</td><td align="char" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Women</td><td align="char" valign="top" rowspan="1" colspan="1">103 (38%)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="char" valign="top" rowspan="1" colspan="1">30 (27%)</td><td align="char" valign="top" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><p>Although these are cumulative/raw data, they confirm that there is a reduced susceptibility of women to severe outcomes from COVID&#x02010;19 infection. Due to the differences between pre&#x02010; and post&#x02010;menopausal phases (Horstman, Dillon, Urban, &#x00026; Sheffield&#x02010;Moore,&#x000a0;<xref rid="bph15207-bib-0040" ref-type="ref">2012</xref>), it is reasonable to speculate that there may be a role played by sex hormones in protecting against severe outcome, but it is not the only factor. Therefore, we need to consider other possible reasons for this difference in sex&#x02010;related lethality. First, is this difference confirmed also in populations from other countries? According to the latest publications, such differences in lethality between the two sexes have been shown elsewhere (see Table&#x000a0;<xref rid="bph15207-tbl-0001" ref-type="table">1</xref> and <ext-link ext-link-type="uri" xlink:href="https://globalhealth5050.org/covid19/">https://globalhealth5050.org/covid19/</ext-link>). For instance, in a number of different articles from China, similar data are reported (Chen, Zhou, et al.,&#x000a0;<xref rid="bph15207-bib-0013" ref-type="ref">2020</xref>, Chen, Wu, et al.,&#x000a0;<xref rid="bph15207-bib-0014" ref-type="ref">2020</xref>; Guan et al.,&#x000a0;<xref rid="bph15207-bib-0031" ref-type="ref">2020</xref>; Huang et al.,&#x000a0;<xref rid="bph15207-bib-0041" ref-type="ref">2020</xref>; Wang et al.,&#x000a0;<xref rid="bph15207-bib-0081" ref-type="ref">2020</xref>; Zhou, Yu, et al.,&#x000a0;<xref rid="bph15207-bib-0089" ref-type="ref">2020</xref>). In these studies, severe or deceased patients admitted to intensive care units (ICUs) were predominantly men, while women ranged between 30% (Huang et al.,&#x000a0;<xref rid="bph15207-bib-0041" ref-type="ref">2020</xref>) and 42.2% (Guan et al.,&#x000a0;<xref rid="bph15207-bib-0031" ref-type="ref">2020</xref>). In the largest study available from China (Guan et al.,&#x000a0;<xref rid="bph15207-bib-0031" ref-type="ref">2020</xref>), quite similar percentages to those reported for deceased women in Italy have been observed. Yet, in this latter study, the median age of patients was 47 years (IQR, 35&#x02013;58), and the distribution between sexes according to age was not reported. For the United States, sex disaggregated data on case fatality are not available, but deaths were 57% for males and 43% for women (<ext-link ext-link-type="uri" xlink:href="https://globalhealth5050.org/covid19/">https://globalhealth5050.org/covid19/</ext-link>, accessed on May 13, 2020).</p><p>To sum up, currently available studies suggest that both young and older women are less susceptible to severe infection outcomes, regardless of their nationality. Both hospitalizations in ICUs and death rates are different between sexes (<ext-link ext-link-type="uri" xlink:href="https://globalhealth5050.org/covid19/">https://globalhealth5050.org/covid19/</ext-link> and Table&#x000a0;<xref rid="bph15207-tbl-0001" ref-type="table">1</xref>). Similar observations were already reported for other coronavirus epidemics (Alghamdi et al.,&#x000a0;<xref rid="bph15207-bib-0005" ref-type="ref">2014</xref>; Karlberg, Chong, &#x00026; Lai,&#x000a0;<xref rid="bph15207-bib-0044" ref-type="ref">2004</xref>; Leong et al.,&#x000a0;<xref rid="bph15207-bib-0053" ref-type="ref">2006</xref>).</p><p>Despite this striking evidence for this infection, very few studies consider different therapeutic approaches for the two sexes. As no specific antiviral drugs are yet proposed to treat COVID&#x02010;19 and control disease evolution, a better understanding of the pathogenic mechanisms in the two sexes induced by <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=1034">SARS&#x02010;CoV&#x02010;2</ext-link> is mandatory to characterize new targets.</p></sec><sec id="bph15207-sec-0002"><label>2</label><title>WHY ARE FEWER WOMEN THAN MEN DYING OF COVID&#x02010;19?</title><p>Fewer women, both young and old, are dying than age&#x02010;matched males. Beside hormone differences, which, however, do not appear to be the only factor, there are different potential mechanisms that may explain why women are less prone to severe COVID&#x02010;19 infections.</p><p>First of all, the expression and activity of two important factors may be considered, namely, ACE2 and the <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2421">transmembrane protease, serine 2</ext-link> (TMPRSS2; Cheng et al.,&#x000a0;<xref rid="bph15207-bib-0016" ref-type="ref">2015</xref>; Kuba et al.,&#x000a0;<xref rid="bph15207-bib-0052" ref-type="ref">2005</xref>). While ACE2 is the receptor for the <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3114">spike (S) protein</ext-link> of coronaviruses, TMPRSS2 splits the S&#x02010;protein at sites S1/S2 and S2, favouring the attachment and fusion of the virus to cell membranes, respectively. ACE2 is largely expressed in organs mainly targeted and damaged by SARS&#x02010;CoV&#x02010;2 (Pagliaro &#x00026; Penna,&#x000a0;<xref rid="bph15207-bib-0063" ref-type="ref">2005</xref>). Both ACE2 and TMPRSS2 have been proposed as modulators of the different susceptibility to SARS&#x02010;CoV in both sexes (Hoffmann et al.,&#x000a0;<xref rid="bph15207-bib-0037" ref-type="ref">2020</xref>).</p><sec id="bph15207-sec-0003"><label>2.1</label><title>Is there a role for ACE/ACE2 ratio in sex difference in COVID&#x02010;19?</title><p>ACE2 is located on the X chromosome and is one of the genes escaping X inactivation (Tukiainen et al.,&#x000a0;<xref rid="bph15207-bib-0079" ref-type="ref">2017</xref>). Therefore, it is likely that this plays an important role in determining protection in women. It can be hypothesized that the second X chromosome could protect females from fatal polymorphisms that make the COVID&#x02010;19 more aggressive in males, for example, by favouring coronavirus binding. Indeed, in a recent study, worse outcome in older COVID&#x02010;19 patients has been attributed to the presence of lower ACE&#x02010;2 levels and the subsequent up&#x02010;regulation of <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2504">angiotensin II</ext-link> (Ang II) proinflammatory pathways throughout the body, which could make patients more prone to systemic &#x0201c;deleterious&#x0201d; effects of Ang II (AlGhatrif, Cingolani, &#x00026; Lakatta,&#x000a0;<xref rid="bph15207-bib-0006" ref-type="ref">2020</xref>). ACE and ACE2 and their major products, Ang II and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=582">Ang&#x02010;1&#x02010;7</ext-link>, respectively, are linked in almost a ying/yang process, when one decreases the other increases and vice versa (Koni &#x00026; Miyamori,&#x000a0;<xref rid="bph15207-bib-0050" ref-type="ref">2007</xref>; Pagliaro &#x00026; Penna,&#x000a0;<xref rid="bph15207-bib-0063" ref-type="ref">2005</xref>; Wang et al.,&#x000a0;<xref rid="bph15207-bib-0083" ref-type="ref">2015</xref>; Wang, Zhang, Yuan, Wu, &#x00026; Li,&#x000a0;<xref rid="bph15207-bib-0082" ref-type="ref">2016</xref>).</p><p>Clearly, ACE2 permits virus entry into cells, but ACE2 overexpression may protect against damage (by reducing Ang II and forming Ang&#x02010;1&#x02010;7; Bukowska et al.,&#x000a0;<xref rid="bph15207-bib-0008" ref-type="ref">2017</xref>; Cheng, Wang, &#x00026; Wang,&#x000a0;<xref rid="bph15207-bib-0015" ref-type="ref">2020</xref>; Patel, Zhong, Grant, &#x00026; Oudit,&#x000a0;<xref rid="bph15207-bib-0066" ref-type="ref">2016</xref>). However, ACE2 can be &#x0201c;shed&#x0201d; from endothelial cells, by a disintegrin and metalloproteinase 17 (<ext-link ext-link-type="uri" xlink:href="http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1662">ADAM17</ext-link>) resulting in the release of a soluble circulating ACE2&#x02010;ectodomain with catalytic function (Patel et al.,&#x000a0;<xref rid="bph15207-bib-0066" ref-type="ref">2016</xref>). Therefore, the picture is complicated by a different ACE/ACE2 ratio in various tissues and by different roles of membrane&#x02010;bound and soluble ACE2. For example, it has been proposed that soluble ACE2 could quench the coronavirus by limiting its attachment to cellular ACE2 (Monteil et al.,&#x000a0;<xref rid="bph15207-bib-0062" ref-type="ref">2020</xref>). However, Sama and colleagues (Sama et al.,&#x000a0;<xref rid="bph15207-bib-0070" ref-type="ref">2020</xref>) demonstrated that male sex is correlated with elevated plasma ACE2 in heart failure (HF) COVID&#x02010;19 patients. Nevertheless, the authors recognize they have no evidence of a correlation between the levels of membrane&#x02010;bound ACE2 and enzyme shedding in the two sexes. Actually, soluble ACE2 is increased in HF with preserved and reduced ejection fraction (Patel et al.,&#x000a0;<xref rid="bph15207-bib-0066" ref-type="ref">2016</xref>). Moreover, the expression of ACE2 seems reduced in post&#x02010;menopausal women (Gagliardi, Tieri, Ortona, &#x00026; Ruggieri,&#x000a0;<xref rid="bph15207-bib-0027" ref-type="ref">2020</xref>; Hilliard, Sampson, Brown, &#x00026; Denton,&#x000a0;<xref rid="bph15207-bib-0036" ref-type="ref">2013</xref>). Interestingly, transgender males exposed to oestrogen (<ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1013">estradiol</ext-link>) and androgen deprivation (<ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2875">spironolactone</ext-link>) therapies display significantly higher ACE2 expression levels and a higher number of ACE2&#x02010;expressing Sertoli cells in the testis. As both oestrogens and androgens decrease with age (Horstman et al.,&#x000a0;<xref rid="bph15207-bib-0040" ref-type="ref">2012</xref>), this decline in hormones is likely to contribute to the reduction of ACE2 expression in both sexes with ageing. However, a 2017 study showed no differences in ACE and ACE2 serum activity between the two sexes, while a lower ACE2 serum activity was observed in younger compared to older women (Fern&#x000e1;ndez&#x02010;Atucha et al.,&#x000a0;<xref rid="bph15207-bib-0025" ref-type="ref">2017</xref>). Overall, it appears that differences in the expression of ACE and ACE2 may be organ&#x02010;specific and age&#x02010;dependent in both sexes, in animals (Xie, Chen, Wang, Zhang, &#x00026; Liu,&#x000a0;<xref rid="bph15207-bib-0084" ref-type="ref">2006</xref>) and humans (Gagliardi et al.,&#x000a0;<xref rid="bph15207-bib-0027" ref-type="ref">2020</xref>; Hilliard et al.,&#x000a0;<xref rid="bph15207-bib-0036" ref-type="ref">2013</xref>) with a less clear role for soluble ACE2 (Monteil et al.,&#x000a0;<xref rid="bph15207-bib-0062" ref-type="ref">2020</xref>; Patel et al.,&#x000a0;<xref rid="bph15207-bib-0066" ref-type="ref">2016</xref>; Sama et al.,&#x000a0;<xref rid="bph15207-bib-0070" ref-type="ref">2020</xref>).</p><p>Whether ACE2 levels in the lung are related to the susceptibility and severity of COVID&#x02010;19 infection is a matter of investigation (Gheblawi et al.,&#x000a0;<xref rid="bph15207-bib-0029" ref-type="ref">2020</xref>). In a preprint paper, it is reported that men may have higher expression of ACE2 in the lungs compared to women (Zhao et al.,&#x000a0;<xref rid="bph15207-bib-0088" ref-type="ref">2020</xref>), with potentially important consequences for COVID&#x02010;19 infections, as the respiratory tract is the entry route for SARS&#x02010;CoV&#x02010;2. However, polymorphisms in both ACE and ACE2 genes can explain the increased capillary permeability, coagulation, fibrosis, and apoptosis of alveolar cells, observed in SARS and COVID&#x02010;19 (Gemmati et al.,&#x000a0;<xref rid="bph15207-bib-0028" ref-type="ref">2020</xref>; Tikellis &#x00026; Thomas,&#x000a0;<xref rid="bph15207-bib-0077" ref-type="ref">2012</xref>). These effects can explain lung damage and respiratory failure (see also below Section&#x000a0;<xref rid="bph15207-sec-0006" ref-type="sec">3</xref>).</p><p>All in all, the role of ACE2 in the pathophysiology of COVID&#x02010;19 is not completely clear: it may act as a Trojan horse, but most evidence indicates that a low membrane&#x02010;bound ACE/ACE2 ratio may be beneficial. Indeed, ACE may be pro&#x02010;inflammatory and pro&#x02010;oxidant, whereas ACE2 may mediate antioxidant and anti&#x02010;inflammatory effects (Pagliaro &#x00026; Penna,&#x000a0;<xref rid="bph15207-bib-0063" ref-type="ref">2005</xref>, <xref rid="bph15207-bib-0064" ref-type="ref">2020</xref>). Soluble ACE2 is higher in HF; whether this is protective or dangerous or is just an epiphenomenon is not clear yet. Nevertheless, the inhibition of ACE2 shedding, by regulating the activity of ADAM17 enzyme, has been suggested as a potential therapeutic approach in HF (Patel et al.,&#x000a0;<xref rid="bph15207-bib-0066" ref-type="ref">2016</xref>).</p><p>Throughout the body, because the expression of ACE2 on the X chromosome can be influenced by oestrogens, the ACE/ACE2 ratio may be shifted towards the ACE2/Ang&#x02010;1&#x02010;7/<ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=150">MAS</ext-link> receptor axis more in women than in men (Chappell, Marshall, Alzayadneh, Shaltout, &#x00026; Diz,&#x000a0;<xref rid="bph15207-bib-0012" ref-type="ref">2014</xref>; Hilliard et al.,&#x000a0;<xref rid="bph15207-bib-0036" ref-type="ref">2013</xref>; Li, Zhou, Yang, &#x00026; You,&#x000a0;<xref rid="bph15207-bib-0054" ref-type="ref">2020</xref>; Tukiainen et al.,&#x000a0;<xref rid="bph15207-bib-0079" ref-type="ref">2017</xref>). This might explain why women are protected against severe COVID&#x02010;19 outcome. However, we have to acknowledge that there are tissue&#x02010; and organ&#x02010;specific differences of the ACE/ACE2 ratio, which can be also influenced by exercise (Crisafulli &#x00026; Pagliaro,&#x000a0;<xref rid="bph15207-bib-0021" ref-type="ref">2020</xref>) and medical conditions (Chappell et al.,&#x000a0;<xref rid="bph15207-bib-0012" ref-type="ref">2014</xref>; Colucci et al.,&#x000a0;<xref rid="bph15207-bib-0018" ref-type="ref">2011</xref>; Li et al.,&#x000a0;<xref rid="bph15207-bib-0054" ref-type="ref">2020</xref>; Yuan et al.,&#x000a0;<xref rid="bph15207-bib-0086" ref-type="ref">2015</xref>). Whether the lethality of SARS&#x02010;CoV&#x02010;2 is mainly due to virus entry and replication or to exaggerated inflammatory response is not clear yet. Nevertheless, the beneficial effects by anti&#x02010;inflammatory drugs (see below) suggest an important role for inflammation and &#x0201c;cytokine storm&#x0201d; in COVID&#x02010;19 lethality (see below).</p></sec><sec id="bph15207-sec-0004"><label>2.2</label><title>Is there a role for TMPRSS2 in sex differences in COVID&#x02010;19?</title><p>Although some studies suggest that TMPRSS2 is involved in determining severity of influenza in animals and humans (Cheng et al.,&#x000a0;<xref rid="bph15207-bib-0016" ref-type="ref">2015</xref>; Sakai et al.,&#x000a0;<xref rid="bph15207-bib-0069" ref-type="ref">2015</xref>), its role during coronavirus infections and in the modulation of COVID&#x02010;19 severity is still unclear. Nevertheless, we have to consider that TMPRSS2 is mainly a <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2858">testosterone</ext-link>&#x02010;regulated gene and may have a higher expression in men than in women (Tomlins et al.,&#x000a0;<xref rid="bph15207-bib-0078" ref-type="ref">2005</xref>), thus suggesting that COVID&#x02010;19 severity could be partially explained by TMPRSS2 up&#x02010;regulation in males (McCoy et al.,&#x000a0;<xref rid="bph15207-bib-0060" ref-type="ref">2020</xref>; Sharifi &#x00026; Ryan,&#x000a0;<xref rid="bph15207-bib-0073" ref-type="ref">2020</xref>; Wambier &#x00026; Goren,&#x000a0;<xref rid="bph15207-bib-0080" ref-type="ref">2020</xref>). Nevertheless, TMPRSS2 expression levels and function are also regulated by oestrogen&#x02010;dependent signalling (Setlur et al.,&#x000a0;<xref rid="bph15207-bib-0072" ref-type="ref">2008</xref>). Intriguingly, an age&#x02010;dependent, different and overlapping expression of ACE2 and TMPRSS2 has been recently described in bronchial cells (Lukassen et al.,&#x000a0;<xref rid="bph15207-bib-0057" ref-type="ref">2020</xref>), but whether this may explain sex differences is still unknown. Therefore, the role of TMPRSS2 in determining sex differences in COVID&#x02010;19 severity needs to be further studied, as protease inhibitors seem effective in limiting SARS&#x02010;CoV&#x02010;2 cell entry (Hoffmann et al.,&#x000a0;<xref rid="bph15207-bib-0037" ref-type="ref">2020</xref>).</p></sec><sec id="bph15207-sec-0005"><label>2.3</label><title>Is there a role for other X or Y&#x02010;linked genes in sex difference in COVID&#x02010;19?</title><p>Several other X&#x02010;linked genes (such as those for the ILs, FOXP3, XIST, and TLR7/8) and Y&#x02010;linked genes (SRY and SOX9) may also explain sex differences (Ghosh &#x00026; Klein,&#x000a0;<xref rid="bph15207-bib-0030" ref-type="ref">2017</xref>). These and other immune regulatory genes encoded by the X and Y chromosomes may explain lower viral loads and reduced inflammation in women compared to men (Conti &#x00026; Younes,&#x000a0;<xref rid="bph15207-bib-0019" ref-type="ref">2020</xref>; M&#x000e1;rquez, Trowbridge, Kuchel, Banchereau, &#x00026; Ucar,&#x000a0;<xref rid="bph15207-bib-0059" ref-type="ref">2020</xref>; Table&#x000a0;<xref rid="bph15207-tbl-0002" ref-type="table">2</xref>). In particular, the two X chromosomes seem to regulate the immune system even if one of them is inactive. The X chromosome regulates the immune system also modulating other proteins, including <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5077">CD40L</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=70">CXCR3</ext-link>, and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1758">TLR8</ext-link>. These can be up&#x02010;regulated in women and can determine the response to viral infections as well as to vaccinations. A differentially expressed genes (DEGs) network was constructed to identify a specific gene signature characterizing SARS&#x02010;CoV&#x02010;2 infection (Fagone et al.,&#x000a0;<xref rid="bph15207-bib-0024" ref-type="ref">2020</xref>). Intriguingly, 10 DEGs were modulated by sex hormones. Six DEGs were <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=628">androgen receptor&#x02010;</ext-link>regulated, with genes for <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=808">CCL20</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=819">CXCL1</ext-link> being up&#x02010;regulated, whereas those for THBD, HEY2, BBOX1 and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1552">MYLK</ext-link> were down&#x02010;regulated. Four DEGs were regulated by <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=620%26familyId=96%26familyType=NHR">oestrogen receptor&#x02010;&#x003b1;</ext-link>, with C3 and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=989">EDN1</ext-link> genes being up&#x02010;regulated and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2144">PDK4</ext-link> and VTCN1 down&#x02010;regulated. Moreover, sex differences in the immune response, determined by genes and hormones (Ghosh &#x00026; Klein,&#x000a0;<xref rid="bph15207-bib-0030" ref-type="ref">2017</xref>; Klein &#x00026; Flanagan,&#x000a0;<xref rid="bph15207-bib-0047" ref-type="ref">2016</xref>), may play an important role in modulating the severity of COVID&#x02010;19. Also, the number of CD4<sup>+</sup> T cells differs between sexes, being higher in women with a better immune response (Conti &#x00026; Younes,&#x000a0;<xref rid="bph15207-bib-0019" ref-type="ref">2020</xref>). Finally, the number of sex&#x02010;independent, non&#x02010;genetic factors that can change susceptibility and mortality is enormous, and many other factors are likely to be considered, including gender and cultural habits in different countries. For example, an outbreak in the Republic of Korea exhibited a high incidence of cases in women due to social and religious events occurring at the time (Report on the Epidemiological Features of Coronavirus Disease 2019 [COVID&#x02010;19] Outbreak in the Republic of Korea from January 19 to March 2, 2020). Smoking can be another gender&#x02010;related habit and independent risk factor for COVID&#x02010;19 exacerbation. Nevertheless, the role of smoking on ACE/ACE2 ratio and function is not clear. In different studies, both an increase in ACE2 expression (Cai,&#x000a0;<xref rid="bph15207-bib-0009" ref-type="ref">2020</xref>) and a decrease in enzyme activity have been described (Yuan et al.,&#x000a0;<xref rid="bph15207-bib-0086" ref-type="ref">2015</xref>). We can speculate that higher levels of ACE2 (more virus receptors) may allow for more virus entry, while ACE2 down&#x02010;regulation (less protection conferred by ACE2 anti&#x02010;inflammatory function) may explain, at least in part, COVID&#x02010;19 severity in smokers.</p><table-wrap id="bph15207-tbl-0002" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 2</label><caption><p>Summary of factors that may be involved in the different response to SARS&#x02010;CoV&#x02010;2 between sexes</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Gene</th><th align="left" valign="bottom" rowspan="1" colspan="1">Function/role in viral infection</th><th align="left" valign="bottom" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">X&#x02010;linked</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ACE2</td><td align="left" valign="top" rowspan="1" colspan="1">Antioxidant anti&#x02010;inflammatory enzyme&#x02010;receptor of Sars&#x02010;Covs</td><td rowspan="6" align="left" valign="top" colspan="1">Pagliaro and Penna&#x000a0;(<xref rid="bph15207-bib-0063" ref-type="ref">2005</xref>); Cheng et al.&#x000a0;(<xref rid="bph15207-bib-0016" ref-type="ref">2015</xref>); Ghosh and Klein&#x000a0;(<xref rid="bph15207-bib-0030" ref-type="ref">2017</xref>); M&#x000e1;rquez et al.&#x000a0;(<xref rid="bph15207-bib-0059" ref-type="ref">2020</xref>)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ILs</td><td align="left" valign="top" rowspan="1" colspan="1">Cytokines involved in the regulation of the immune response</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">FOXP3</td><td rowspan="2" align="left" valign="top" colspan="1">Transcription factor involved in the development and function of regulatory T cells</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">XIST</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">TLRs</td><td rowspan="2" align="left" valign="top" colspan="1">Receptor involved in pathogen recognition and activation of the innate immunity</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CXCR3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Y&#x02010;linked</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">TMPRSS2</td><td align="left" valign="top" rowspan="1" colspan="1">Transmembrane protease promotes cell entrance of coronavirus</td><td rowspan="3" align="left" valign="top" colspan="1">Tomlins et al.&#x000a0;(<xref rid="bph15207-bib-0078" ref-type="ref">2005</xref>); Ghosh and Klein&#x000a0;(<xref rid="bph15207-bib-0030" ref-type="ref">2017</xref>); M&#x000e1;rquez et al.&#x000a0;(<xref rid="bph15207-bib-0059" ref-type="ref">2020</xref>)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">SRY</td><td align="left" valign="top" rowspan="1" colspan="1">Encodes for proteins involved in the immune response during viral infections</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">SOX9</td><td align="left" valign="top" rowspan="1" colspan="1">Encodes for proteins involved in the immune response to viral infections</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Genes regulated by sexual hormones</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Effects</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oestrogens</td><td align="left" valign="top" rowspan="1" colspan="1"/><td rowspan="5" align="left" valign="top" colspan="1">Setlur et al.&#x000a0;(<xref rid="bph15207-bib-0072" ref-type="ref">2008</xref>); Bukowska et al.&#x000a0;(<xref rid="bph15207-bib-0008" ref-type="ref">2017</xref>); Fagone et al.&#x000a0;(<xref rid="bph15207-bib-0024" ref-type="ref">2020</xref>)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ACE2</td><td align="left" valign="top" rowspan="1" colspan="1">Up&#x02010;regulation in several tissues (e.g., lungs and heart)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">TMPRSS2</td><td align="left" valign="top" rowspan="1" colspan="1">Fusion of the promoter region of TMPRSS2 gene to the coding region of ERG</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" valign="top" colspan="1">DEGs</td><td align="left" valign="top" rowspan="1" colspan="1">Up&#x02010;regulation of C3 and EDN1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Down&#x02010;regulation of PDK4 and VTCN1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Androgens</td><td align="left" valign="top" rowspan="1" colspan="1"/><td rowspan="4" align="left" valign="top" colspan="1">Tomlins et al.&#x000a0;(<xref rid="bph15207-bib-0078" ref-type="ref">2005</xref>); Fagone et al.&#x000a0;(<xref rid="bph15207-bib-0024" ref-type="ref">2020</xref>)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">TMPRSS2</td><td align="left" valign="top" rowspan="1" colspan="1">Up&#x02010;regulation in several tissues (e.g., prostate cancer)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="2" valign="top" colspan="1">DEGs</td><td align="left" valign="top" rowspan="1" colspan="1">Up&#x02010;regulation of CCL20 and CXCL1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Down&#x02010;regulation of THBD, HEY2, BBOX1, and MYLK</td></tr></tbody></table><table-wrap-foot id="bph15207-ntgp-0001"><fn id="bph15207-note-0001"><p>Abbreviations: BBOX1, &#x003b3;&#x02010;butyrobetaine hydroxylase 1; C3, complement C3; DEGs, differentially expressed genes; EDN1, endothelin 1; ERG, v&#x02010;ets erythroblastosis virus E26 oncogene homolog (avian); FOXP3, forkhead box transcription factor; HEY2, hairy/enhancer&#x02010;of&#x02010;split related with YRPW motif protein; MYLK, myosin light chain kinase; PDK4, pyruvate dehydrogenase lipoamide kinase isozyme 4; SOX9, sex&#x02010;determining region Y box 9; SRY, sex&#x02010;determining region Y; THBD, thrombomodulin; TLRs, Toll&#x02010;like receptors; TMPRSS2, transmembrane protease serine 2; VTCN1, V&#x02010;set domain containing T cell activation inhibitor 1; XIST, X inactive specific transcript.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="bph15207-sec-0006"><label>3</label><title>SEX, PULMONARY DISEASE AND COVID&#x02010;19</title><p>Respiratory droplets that spread every time while breathing, coughing, or sneezing are the main route of transmission of SARS&#x02010;CoV&#x02010;2. Therefore, attachment of the virus to ACE2 expressed on the respiratory tract is the first step enabling entry into host cells. Therefore, COVID&#x02010;19 primarily affects the respiratory system and secondary acute respiratory distress syndrome (ARDS) is quite prevalent in COVID&#x02010;19 patients (Cheng et al.,&#x000a0;<xref rid="bph15207-bib-0015" ref-type="ref">2020</xref>; Zhou, Yang, et al.,&#x000a0;<xref rid="bph15207-bib-0091" ref-type="ref">2020</xref>). In this respect, the comparison with epidemiological evidence from influenza outbreaks and pandemics is very interesting. Opposite to COVID&#x02010;19, in influenza, morbidity and mortality are often higher for women than men. Moreover, during influenza, &#x0201c;cytokine storms&#x0201d; do not clearly differ between men and women (Klein, Hodgson, &#x00026; Robinson,&#x000a0;<xref rid="bph15207-bib-0048" ref-type="ref">2012</xref>). On the other hand, COVID&#x02010;19 elderly male patients have a greater inflammatory reaction, with higher levels of interleukins, <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5074">TNF&#x02010;&#x003b1;</ext-link>, LDH, ferritin and hsCRP, thus developing a &#x0201c;cytokine storm,&#x0201d; which may lead to ARDS, multiple organ failure and, ultimately, death (Moccia et al.,&#x000a0;<xref rid="bph15207-bib-0061" ref-type="ref">2020</xref>; Qin et al.,&#x000a0;<xref rid="bph15207-bib-0068" ref-type="ref">2020</xref>). Of note, serum levels of interleukins (s<ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2297%26familyId=305%26familyType=CATALYTICRECEPTOR">IL&#x02010;2R</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4998">IL&#x02010;6</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=821">IL&#x02010;8</ext-link>, and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4975">IL&#x02010;10</ext-link>) and TNF&#x02010;&#x003b1; were measured in women and men with and without apparent comorbidities. Male COVID&#x02010;19 patients displayed an exaggerated production of inflammatory cytokines and proteins (Qin et al.,&#x000a0;<xref rid="bph15207-bib-0068" ref-type="ref">2020</xref>), including the anti&#x02010;inflammatory IL&#x02010;10 (Iyer &#x00026; Cheng,&#x000a0;<xref rid="bph15207-bib-0042" ref-type="ref">2012</xref>).</p><p>Epigenetics may play a role in the different response to the virus. Indeed, some studies suggest that different viruses utilize different epigenetic mechanisms to mediate antigen presentation and gene expression (Menachery et al.,&#x000a0;<xref rid="bph15207-bib-0093" ref-type="ref">2018</xref>). Sex hormones influence epigenetic regulation of gene expression in the immune response (Klein &#x00026; Flanagan,&#x000a0;<xref rid="bph15207-bib-0047" ref-type="ref">2016</xref>). Epigenetic compounds (Kiss et al.,&#x000a0;<xref rid="bph15207-bib-0046" ref-type="ref">2019</xref>; Moccia et al.,&#x000a0;<xref rid="bph15207-bib-0061" ref-type="ref">2020</xref>; Pooladanda et al.,&#x000a0;<xref rid="bph15207-bib-0067" ref-type="ref">2019</xref>) could then restore the stress resilience of both epithelial and cardiac cells in COVID&#x02010;19 patients. However, dietary intake of functional foods and regular physical exercise (Crisafulli &#x00026; Pagliaro,&#x000a0;<xref rid="bph15207-bib-0021" ref-type="ref">2020</xref>; Lionetti, Tuana, Casieri, Parikh, &#x00026; Pierce,&#x000a0;<xref rid="bph15207-bib-0055" ref-type="ref">2019</xref>) may activate Nrf2 in a variety of tissues and could be suggested to patients who present with only a few symptoms, in order to reduce the risk of major complications from COVID&#x02010;19. Indeed, exercise is a natural way to increase the expression of ACE2 and to reduce the ACE/ACE2 ratio also in the respiratory tract (Crisafulli &#x00026; Pagliaro,&#x000a0;<xref rid="bph15207-bib-0021" ref-type="ref">2020</xref>).</p><p>Importantly, ACE2 may be protective against ARDS. In mice, ACE2 down&#x02010;regulation favoured more severe lung failure (Cheng et al.,&#x000a0;<xref rid="bph15207-bib-0015" ref-type="ref">2020</xref>; Hanff, Harhay, Brown, Cohen, &#x00026; Mohareb,&#x000a0;<xref rid="bph15207-bib-0034" ref-type="ref">2020</xref>; Kuba et al.,&#x000a0;<xref rid="bph15207-bib-0052" ref-type="ref">2005</xref>). Another study (Xie et al.,&#x000a0;<xref rid="bph15207-bib-0084" ref-type="ref">2006</xref>) in rats showed that lung expression of ACE2 is drastically reduced with ageing in both sexes. As mentioned, the binding of SARSCoV&#x02010;2 spike to ACE2 down&#x02010;regulates ACE2, thus decreasing <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=649">bradykinin</ext-link> and Ang II catabolism, as well as Ang&#x02010;1&#x02010;7 formation. The dysregulation of these factors may explain the pathogenesis of respiratory failure and pulmonary hypertension (Gurwitz,&#x000a0;<xref rid="bph15207-bib-0032" ref-type="ref">2020</xref>; Horn, Chakinala, Oudiz, Joseloff, &#x00026; Rosenzweig,&#x000a0;<xref rid="bph15207-bib-0039" ref-type="ref">2020</xref>). Moreover, bradykinin accumulation may explain inflammatory processes, cough and fever. Bradykinin also favours both the complement system and coagulation, mechanisms typical of angioedema, sepsis, and cardiovascular dysfunction, as found in COVID&#x02010;19 patients (Colarusso, Terlizzi, Pinto, &#x00026; Sorrentino,&#x000a0;<xref rid="bph15207-bib-0017" ref-type="ref">2020</xref>). Actually, a large number of COVID&#x02010;19 patients exhibit severe cardiovascular damage (Moccia et al.,&#x000a0;<xref rid="bph15207-bib-0061" ref-type="ref">2020</xref>) and, as reported above, patients with pre&#x02010;existing cardiovascular diseases (CVDs) appear to have an increased risk of death (also see below).</p></sec><sec id="bph15207-sec-0007"><label>4</label><title>SEX, CARDIOVASCULAR DISEASE AND COVID&#x02010;19</title><p>Cardiovascular disease is more prevalent in males, and subjects with cardiovascular dysfunction infected with SARS&#x02010;CoV&#x02010;2 have a worse prognosis. As already discussed, the poor prognosis of patients with COVID&#x02010;19 is related to factors such as male sex, ageing, and underlying diseases, especially dysmetabolic and CVDs (see AlGhatrif et al.,&#x000a0;<xref rid="bph15207-bib-0006" ref-type="ref">2020</xref>; Moccia et al.,&#x000a0;<xref rid="bph15207-bib-0061" ref-type="ref">2020</xref>). For example, among the deceased COVID&#x02010;19 patients in Italy, less than 4% had no comorbidity, while more than 60% had three or more comorbidities. Among these, cardiovascular comorbidities were the most represented and included arterial hypertension (about 70% of deceased patients), followed by ischaemic heart disease (about 30%), atrial fibrillation (about 20%), and HF (about 15%; <ext-link ext-link-type="uri" xlink:href="https://www.iss.it/coronavirus">https://www.iss.it/coronavirus</ext-link>, accessed on May 13, 2020). Most of the deceased patients were elderly (over 65 years) and obese (in the Italian report, obesity is present in 12% of the deceased patients). All these conditions are characterized by an abnormal ACE/ACE2 ratio in humans and animals (Colucci et al.,&#x000a0;<xref rid="bph15207-bib-0018" ref-type="ref">2011</xref>; Koni &#x00026; Miyamori,&#x000a0;<xref rid="bph15207-bib-0050" ref-type="ref">2007</xref>; Santos et al.,&#x000a0;<xref rid="bph15207-bib-0071" ref-type="ref">2013</xref>; Wang et al.,&#x000a0;<xref rid="bph15207-bib-0083" ref-type="ref">2015</xref>, <xref rid="bph15207-bib-0082" ref-type="ref">2016</xref>). It appears that an abnormal ACE/ACE2 ratio is responsible, not only for a high incidence of severe ARDS but also for cardiovascular complications and the high lethality of COVID&#x02010;19. Oestrogens up&#x02010;regulate the expression of ACE2 in human atrial tissue (Bukowska et al.,&#x000a0;<xref rid="bph15207-bib-0008" ref-type="ref">2017</xref>), explaining the higher ACE2 expression in the heart of women. As early as 2002, immediately after the discovery of ACE2, a sex&#x02010;dependent role of ACE2 in HF, with less severe impairment in female than in male mice, has been described and subsequently confirmed (Crackower et al.,&#x000a0;<xref rid="bph15207-bib-0020" ref-type="ref">2002</xref>; Patel et al.,&#x000a0;<xref rid="bph15207-bib-0066" ref-type="ref">2016</xref>). SARS&#x02010;CoV&#x02010;2 down&#x02010;regulates ACE2, and this may favour the ACE/<ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=34">AT<sub>1</sub> receptor</ext-link> axis and may predispose to CVDs (Horn et al.,&#x000a0;<xref rid="bph15207-bib-0039" ref-type="ref">2020</xref>). Indeed, down&#x02010;regulation of ACE2 has been observed in pulmonary arterial hypertension. ACE2 down&#x02010;regulation and inflammatory response may favour endothelial dysfunction and coagulopathy, thus worsening the CVD (Guzik et al.,&#x000a0;<xref rid="bph15207-bib-0033" ref-type="ref">2020</xref>; Moccia et al.,&#x000a0;<xref rid="bph15207-bib-0061" ref-type="ref">2020</xref>). Therefore, the lower ACE/ACE2 ratio in the female heart may limit coagulopathy and COVID&#x02010;19&#x02010;induced exacerbation of CVD (Gemmati et al.,&#x000a0;<xref rid="bph15207-bib-0028" ref-type="ref">2020</xref>; Moccia et al.,&#x000a0;<xref rid="bph15207-bib-0061" ref-type="ref">2020</xref>).</p><p>Therefore, re&#x02010;establishing an adequate ACE/ACE2 ratio may lead to better outcomes in COVID&#x02010;19. Indeed, COVID&#x02010;19 depletes and down&#x02010;regulates ACE2 (Moccia et al.,&#x000a0;<xref rid="bph15207-bib-0061" ref-type="ref">2020</xref>). Therefore, the anti&#x02010;inflammatory effect of drugs that activate ACE2 may be exploited as a potential therapy in this setting (Figure&#x000a0;<xref rid="bph15207-fig-0001" ref-type="fig">1</xref>). Of note, oestrogens significantly down&#x02010;regulate ACE levels while up&#x02010;regulating ACE2 and MAS receptor expression, thus shifting from the classical RAS/ACE/AT<sub>1</sub> receptor axis to the protective RAS/ACE2/MAS axis (Bukowska et al.,&#x000a0;<xref rid="bph15207-bib-0008" ref-type="ref">2017</xref>). Already in 2017, it was proposed that oestrogens have a protective role in SARS by regulating immune response and limiting SARS&#x02010;CoV replication directly (Channappanavar et al.,&#x000a0;<xref rid="bph15207-bib-0011" ref-type="ref">2017</xref>). Therefore, exogenous oestrogen administration has been proposed for both male and female COVID&#x02010;19 patients (Cutolo, Smith, &#x00026; Paolino,&#x000a0;<xref rid="bph15207-bib-0022" ref-type="ref">2020</xref>; Suba,&#x000a0;<xref rid="bph15207-bib-0075" ref-type="ref">2020</xref>), and a couple of Clinical Trials on the role of sex hormones in COVID&#x02010;19 patients are already ongoing (NCT04359329 and NCT04365127). Animal studies on drugs that can limit SARS&#x02010;CoV&#x02010;2 effects are lacking. Preliminary studies report that this virus may infect ferrets, hamsters, and cats, inducing mild symptoms, but not pigs or birds (Chan et al.,&#x000a0;<xref rid="bph15207-bib-0010" ref-type="ref">2020</xref>; Shi et al.,&#x000a0;<xref rid="bph15207-bib-0074" ref-type="ref">2020</xref>). Interestingly, a very recent preliminary study shows that mice overexpressing human ACE2 may develop COVID&#x02010;19&#x02010;like signs in response to infection with SARS&#x02010;CoV&#x02010;2 (Jiang et al.,&#x000a0;<xref rid="bph15207-bib-0043" ref-type="ref">2020</xref>). These animals showed different susceptibility and, intriguingly, the male mice showed a higher death rate than the females.</p><fig fig-type="FIGURE" xml:lang="en" id="bph15207-fig-0001" orientation="portrait" position="float"><label>FIGURE 1</label><caption><p>Possible role of ACE/ACE2 ratio in therapies against COVID&#x02010;19 in the two sexes. It has been proposed that pathological conditions presenting with a high ACE/ACE2 ratio predispose towards worse COVID&#x02010;19 outcomes (Gemmati et al.,&#x000a0;<xref rid="bph15207-bib-0028" ref-type="ref">2020</xref>; Pagliaro &#x00026; Penna,&#x000a0;<xref rid="bph15207-bib-0064" ref-type="ref">2020</xref>). ACE2 is a membrane&#x02010;bound enzyme, whose gene lies on the X chromosome and is up&#x02010;regulated by oestrogens in males and females. Throughout the body, the ACE/ACE2 ratio may be lower in women than in men, and this is theoretically protective because of the anti&#x02010;inflammatory properties of ACE2. However, it must be kept in mind that ACE2 in the lung may act as the entry gate for COVID&#x02010;19, and the ACE/ACE2 ratio may be different in tissues and organs, and that this ratio is influenced by many factors including, exercise, ageing, and diseases (Crisafulli &#x00026; Pagliaro,&#x000a0;<xref rid="bph15207-bib-0021" ref-type="ref">2020</xref>). Therefore, more studies are necessary to clarify the role of the ACE/ACE2 ratio in the two sexes</p></caption><graphic id="nlm-graphic-1" xlink:href="BPH-177-4375-g001"/></fig></sec><sec id="bph15207-sec-0008"><label>5</label><title>OTHER PROPOSED DRUGS</title><p>Drugs that can increase ACE2 activity include <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=590">losartan</ext-link> (NCT04312009, NCT04311177, NCT04340557, and NCT04343001; <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov">clinicaltrials.gov</ext-link>), <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10307">diminazene diaceturate</ext-link>, resorcinol naphthalein, and xantenone (Li et al.,&#x000a0;<xref rid="bph15207-bib-0054" ref-type="ref">2020</xref>). Also, AT<sub>1</sub> receptor antagonists have been considered as anti&#x02010;COVID&#x02010;19 therapeutics (Gurwitz,&#x000a0;<xref rid="bph15207-bib-0032" ref-type="ref">2020</xref>). Furthermore, recombinant ACE2 has been proposed in both pneumonia (Khan et al.,&#x000a0;<xref rid="bph15207-bib-0045" ref-type="ref">2017</xref>) and COVID&#x02010;19 (Monteil et al.,&#x000a0;<xref rid="bph15207-bib-0062" ref-type="ref">2020</xref>).</p><p>Currently, <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10715">remdesivir</ext-link>, used against Ebola, and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5535">chloroquine</ext-link>/<ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7198">hydroxychloroquine</ext-link>, used against malaria (Luo et al.,&#x000a0;<xref rid="bph15207-bib-0058" ref-type="ref">2020</xref>; Yazdany &#x00026; Kim,&#x000a0;<xref rid="bph15207-bib-0085" ref-type="ref">2020</xref>), are being used for COVID&#x02010;19 patients. Between the submission and revision of this review article, safety concerns have been raised about the chloroquine/hydroxylchloroquine use in COVID&#x02010;19, and the discussion is still open (Paliani &#x00026; Cardona,&#x000a0;<xref rid="bph15207-bib-0065" ref-type="ref">2020</xref>).</p><p>A &#x0201c;cytokine storm&#x0201d; has been proposed several times as responsible for COVID&#x02010;19 lethality (e.g., Moccia et al.,&#x000a0;<xref rid="bph15207-bib-0061" ref-type="ref">2020</xref>; Qin et al.,&#x000a0;<xref rid="bph15207-bib-0068" ref-type="ref">2020</xref>) and, consequently, the anti&#x02010;IL&#x02010;6 receptor antibody, <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6881">tocilizumab</ext-link> (used for the treatment of rheumatoid arthritis and CRS after CAR&#x02010;T therapies; Alvi et al.,&#x000a0;<xref rid="bph15207-bib-0007" ref-type="ref">2019</xref>), has been proposed in many clinical studies, and it is now in Phase II and Phase III studies in COVID&#x02010;19 patients (Lu, Chen, &#x00026; Chang,&#x000a0;<xref rid="bph15207-bib-0056" ref-type="ref">2020</xref>; Luo et al.,&#x000a0;<xref rid="bph15207-bib-0058" ref-type="ref">2020</xref>). Monoclonal antibodies, anti&#x02010;IL&#x02010;1 and anti&#x02010;IL&#x02010;6, and plasma derived from COVID&#x02010;19 recovered patients have been proposed (<ext-link ext-link-type="uri" xlink:href="https://www.sciencenews.org/article/coronavirus-covid-19-can-plasma-recovered-patients-treat-sick">https://www.sciencenews.org/article/coronavirus-covid-19-can-plasma-recovered-patients-treat-sick</ext-link>). Other anti&#x02010;inflammatory drugs, including JAK inhibitors, and glucocorticoids may also be useful (Zhang et al.,&#x000a0;<xref rid="bph15207-bib-0087" ref-type="ref">2020</xref>). Indeed, a preliminary study showed that <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2768">dexamethasone</ext-link> was able to reduce 28&#x02010;day mortality among COVID&#x02010;19 patients receiving invasive mechanical ventilation (Horby et al.,&#x000a0;<xref rid="bph15207-bib-0038" ref-type="ref">2020</xref>). Also, blockade of the kallikrein&#x02010;kinin system, upstream of bradykinin, by <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9094">lanadelumab</ext-link> (already used in hereditary angioedema) has been proposed for COVID&#x02010;19 patients (Colarusso et al.,&#x000a0;<xref rid="bph15207-bib-0017" ref-type="ref">2020</xref>). Promising drugs are blockers of TMPRSS2, such as <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6432">camostat</ext-link> mesylate and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4262">nafamostat</ext-link> mesylate (see Zhou, Fang, et al.,&#x000a0;<xref rid="bph15207-bib-0090" ref-type="ref">2020</xref>).</p><p>Coagulopathies are also a prominent aspect of severe Covid&#x02010;19 patients. Thus, anticoagulant treatments may decrease mortality (Kollias et al.,&#x000a0;<xref rid="bph15207-bib-0049" ref-type="ref">2020</xref>; Tang et al.,&#x000a0;<xref rid="bph15207-bib-0076" ref-type="ref">2020</xref>) in an ACE/ACE2 dependent and sex&#x02010;related way (Gemmati et al.,&#x000a0;<xref rid="bph15207-bib-0028" ref-type="ref">2020</xref>). While waiting for vaccines and new therapeutic strategies to fight this terrible pandemic, different antiviral options are under clinical trial as combination therapies. These include hydroxylchloroquine alone or in combination with <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6510">azithromycin</ext-link>, and remdesivir, as well as <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9502">lopinavir</ext-link>/<ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8804">ritonavir</ext-link> alone or with <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4955">interferon</ext-link> (<ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> identifier: NCT04332094, NCT04332107, NCT04322123, NCT04335552, NCT04336332, and NCT04339816). To the best of our knowledge, none of these studies considered different therapeutic approaches for men and women. Moreover, for many of these drugs, the effects on ACE/ACE2 ratio are unknown. Even in vaccination, sex is a variable that should be considered. Indeed, pathogen&#x02010;specific and non&#x02010;specific effects of vaccines present differences between sexes that can be exploited in fighting COVID&#x02010;19 (Aaby et al.,&#x000a0;<xref rid="bph15207-bib-0001" ref-type="ref">2020</xref>). Of note, the antibody response to vaccinations is actually thought to be greater in women than men, and possibly, this might underlie future protection. However, women display more adverse events than men following vaccinations (Fischinger, Boudreau, Butler, Streeck, &#x00026; Alter,&#x000a0;<xref rid="bph15207-bib-0026" ref-type="ref">2019</xref>).</p><p>A recent study (Fagone et al.,&#x000a0;<xref rid="bph15207-bib-0024" ref-type="ref">2020</xref>) investigated the transcriptomic profile in primary human lung cells upon infection with SARS&#x02010;CoV&#x02010;2. In this study, the transcriptomic profile of lung tissue from healthy men and women were compared with the transcriptomic induced by the virus. It emerged that at ages 40&#x02013;60 years, the transcriptomic feature of female lung tissue was more similar to those induced by SARS&#x02010;CoV&#x02010;2 than in male tissue. The authors suggest that a lower threshold of acute response to SARS&#x02010;CoV&#x02010;2 infection in men may, at least partly, explain the lower lethality in women. Nevertheless, the potential factors that might induce this &#x0201c;COVID&#x02010;19&#x02010;resistant lung phenotype&#x0201d; in middle&#x02010;aged women is not clear. In this study, targeting the mammalian target of rapamycin (<ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2109">mTOR</ext-link>) pathway using <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6031">sirolimus</ext-link> appeared to be a promising therapeutic approach to fight COVID&#x02010;19. Also MAPK kinase (MEK), I&#x003ba;B kinase (IKK), and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=285">Akt</ext-link> inhibitors have been proposed as candidate drugs (Fagone et al.,&#x000a0;<xref rid="bph15207-bib-0024" ref-type="ref">2020</xref>). Of note, some of these enzymes are linked to ACE2 anti&#x02010;inflammatory action (Dhawale et al.,&#x000a0;<xref rid="bph15207-bib-0023" ref-type="ref">2016</xref>). Nevertheless, this study does not envisage different therapeutic approaches for men and women.</p></sec><sec id="bph15207-sec-0009"><label>6</label><title>CONCLUSIONS</title><p>Significant sex&#x02010;related differences are present in the rate of severe cases of COVID&#x02010;19. Several potential factors underlying these differences in pathogenic mechanisms are identified at the molecular level. All the above&#x02010;mentioned drugs, targeting these mechanisms, would warrant clinical studies. In particular, the ACE/ACE2 ratio must be considered (Figure&#x000a0;<xref rid="bph15207-fig-0001" ref-type="fig">1</xref>) and drugs that positively influence this ratio should be taken into account. Beside a wide range of factors that may influence outcome, sex should be one of the criteria to consider in order to select the appropriate therapies for the appropriate patients. Indeed, given the striking differences in lethality between the two sexes, we believe that studying sex differences may help to find appropriate therapies for all patients. Only large unbiased studies considering all factors and hypotheses mentioned here concerning sex differences may explain why women are less at risk of dying from COVID&#x02010;19 and might help to find patient&#x02010;tailored therapies. It is, therefore, recommended that sex&#x02010;disaggregated data are provided for all COVID19 studies.</p><sec id="bph15207-sec-0010"><label>6.1</label><title>Nomenclature of targets and ligands</title><p>Key protein targets and ligands in this article are hyperlinked to corresponding entries in <ext-link ext-link-type="uri" xlink:href="http://www.guidetopharmacology.org">http://www.guidetopharmacology.org</ext-link>, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Harding et al.,&#x000a0;<xref rid="bph15207-bib-0035" ref-type="ref">2018</xref>), and are permanently archived in the Concise Guide to PHARMACOLOGY2019/20 (Alexander, Christopoulos, et al.,&#x000a0;<xref rid="bph15207-bib-0002" ref-type="ref">2019</xref>; Alexander, Fabbro, et al.,&#x000a0;<xref rid="bph15207-bib-0003" ref-type="ref">2019a</xref>, <xref rid="bph15207-bib-0004" ref-type="ref">2019b</xref>).</p></sec></sec><sec sec-type="COI-statement" id="bph15207-sec-0012"><title>CONFLICT OF INTEREST</title><p>Relationship: Dr. Tocchetti has a Canadian Patent No. 2,613,477, issued on December 3, 2013 Inventors: Nazareno Paolocci, David A Kass, Carlo G Tocchetti. Owner: Johns Hopkins University Entitled: THIOL&#x02010;SENSITIVE POSITIVE INOTROPES JHU Ref.: C04755&#x02010;P04755&#x02010;05 with royalties paid. No other relationships/conditions/circumstances that present a potential conflict of interest.</p></sec></body><back><ack id="bph15207-sec-0011"><title>ACKNOWLEDGEMENTS</title><p>P.P. and C.G.T. are Members of COST Action EU&#x02010;CARDIOPROTECTION CA16225. C.P. and P.P. report grants from the University of Torino, Ricerca Locale Ex&#x02010;60% (Grants: PAGP_RILO_16_01; PENC_RILO) and from MIUR (PAGP_FFABR_17_01 and by PENC_FFABR_17_01). C.G.T. reports personal fees from Alere, outside the submitted work. V.M. reports a grant from SIC/MSD, outside the submitted work.</p></ack><ref-list id="bph15207-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="bph15207-bib-0001"><mixed-citation publication-type="journal" id="bph15207-cit-0002">
<string-name>
<surname>Aaby</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Benn</surname>, <given-names>C. S.</given-names>
</string-name>, <string-name>
<surname>Flanagan</surname>, <given-names>K. L.</given-names>
</string-name>, <string-name>
<surname>Klein</surname>, <given-names>S. L.</given-names>
</string-name>, <string-name>
<surname>Kollmann</surname>, <given-names>T. R.</given-names>
</string-name>, <string-name>
<surname>Lynn</surname>, <given-names>D. J.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Shann</surname>, <given-names>F.</given-names>
</string-name> (<year>2020</year>). <article-title>The non&#x02010;specific and sex&#x02010;differential effects of vaccines</article-title>. <source xml:lang="en">Nature Reviews. Immunology</source>, <volume>27</volume>, <fpage>1</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/s41577-020-0338-x</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0002"><mixed-citation publication-type="journal" id="bph15207-cit-0003">
<string-name>
<surname>Alexander</surname>, <given-names>S. P. H.</given-names>
</string-name>, <string-name>
<surname>Christopoulos</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Davenport</surname>, <given-names>A. P.</given-names>
</string-name>, <string-name>
<surname>Kelly</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Mathie</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Peters</surname>, <given-names>J. A.</given-names>
</string-name>, &#x02026; 
<collab collab-type="authors">CGTP Collaborators</collab>
. (<year>2019</year>). <article-title>THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein&#x02010;coupled receptors</article-title>. <source xml:lang="en">British Journal of Pharmacology</source>, <volume>176</volume>, <fpage>S21</fpage>&#x02013;<lpage>S141</lpage>. <pub-id pub-id-type="doi">10.1111/bph.14748</pub-id>
<pub-id pub-id-type="pmid">31710717</pub-id></mixed-citation></ref><ref id="bph15207-bib-0003"><mixed-citation publication-type="journal" id="bph15207-cit-0004">
<string-name>
<surname>Alexander</surname>, <given-names>S. P. H.</given-names>
</string-name>, <string-name>
<surname>Fabbro</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Kelly</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Mathie</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Peters</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Veale</surname>, <given-names>E. L.</given-names>
</string-name>, &#x02026; 
<collab collab-type="authors">CGTP Collaborators</collab>
. (<year>2019a</year>). <article-title>THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors</article-title>. <source xml:lang="en">British Journal of Pharmacology</source>, <volume>176</volume>, <fpage>S247</fpage>&#x02013;<lpage>S296</lpage>. <pub-id pub-id-type="doi">10.1111/bph.14751</pub-id>
<pub-id pub-id-type="pmid">31710716</pub-id></mixed-citation></ref><ref id="bph15207-bib-0004"><mixed-citation publication-type="journal" id="bph15207-cit-0005">
<string-name>
<surname>Alexander</surname>, <given-names>S. P. H.</given-names>
</string-name>, <string-name>
<surname>Fabbro</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Kelly</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Mathie</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Peters</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Veale</surname>, <given-names>E. L.</given-names>
</string-name>, &#x02026; 
<collab collab-type="authors">CGTP Collaborators</collab>
. (<year>2019b</year>). <article-title>THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes</article-title>. <source xml:lang="en">British Journal of Pharmacology</source>, <volume>176</volume>, <fpage>S297</fpage>&#x02013;<lpage>S396</lpage>. <pub-id pub-id-type="doi">10.1111/bph.14752</pub-id>
<pub-id pub-id-type="pmid">31710714</pub-id></mixed-citation></ref><ref id="bph15207-bib-0005"><mixed-citation publication-type="journal" id="bph15207-cit-0006">
<string-name>
<surname>Alghamdi</surname>, <given-names>I. G.</given-names>
</string-name>, <string-name>
<surname>Hussain</surname>, <given-names>I. I.</given-names>
</string-name>, <string-name>
<surname>Almalki</surname>, <given-names>S. S.</given-names>
</string-name>, <string-name>
<surname>Alghamdi</surname>, <given-names>M. S.</given-names>
</string-name>, <string-name>
<surname>Alghamdi</surname>, <given-names>M. M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>El&#x02010;Sheemy</surname>, <given-names>M. A.</given-names>
</string-name> (<year>2014</year>). <article-title>The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: A descriptive epidemiological analysis of data from the Saudi Ministry of Health</article-title>. <source xml:lang="en">Int J Gen Med</source>, <volume>7</volume>, <fpage>417</fpage>&#x02013;<lpage>423</lpage>. <pub-id pub-id-type="doi">10.2147/IJGM.S67061</pub-id>
<pub-id pub-id-type="pmid">25187734</pub-id></mixed-citation></ref><ref id="bph15207-bib-0006"><mixed-citation publication-type="journal" id="bph15207-cit-0007">
<string-name>
<surname>AlGhatrif</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Cingolani</surname>, <given-names>O.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Lakatta</surname>, <given-names>E. G.</given-names>
</string-name> (<year>2020</year>). <article-title>The dilemma of coronavirus disease 2019, aging, and cardiovascular disease: Insights from cardiovascular aging science</article-title>. <source xml:lang="en">JAMA Cardiology</source>, <volume>5</volume>, <fpage>747</fpage>
<pub-id pub-id-type="doi">10.1001/jamacardio.2020.1329</pub-id>
<pub-id pub-id-type="pmid">32242886</pub-id></mixed-citation></ref><ref id="bph15207-bib-0007"><mixed-citation publication-type="journal" id="bph15207-cit-0008">
<string-name>
<surname>Alvi</surname>, <given-names>R. M.</given-names>
</string-name>, <string-name>
<surname>Frigault</surname>, <given-names>M. J.</given-names>
</string-name>, <string-name>
<surname>Fradley</surname>, <given-names>M. G.</given-names>
</string-name>, <string-name>
<surname>Jain</surname>, <given-names>M. D.</given-names>
</string-name>, <string-name>
<surname>Mahmood</surname>, <given-names>S. S.</given-names>
</string-name>, <string-name>
<surname>Awadalla</surname>, <given-names>M.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Neilan</surname>, <given-names>T. G.</given-names>
</string-name> (<year>2019</year>). <article-title>Cardiovascular events among adults treated with chimeric antigen receptor T&#x02010;cells (CAR&#x02010;T)</article-title>. <source xml:lang="en">Journal of the American College of Cardiology</source>, <volume>74</volume>(<issue>25</issue>), <fpage>3099</fpage>&#x02013;<lpage>3108</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2019.10.038</pub-id>
<pub-id pub-id-type="pmid">31856966</pub-id></mixed-citation></ref><ref id="bph15207-bib-0008"><mixed-citation publication-type="journal" id="bph15207-cit-0009">
<string-name>
<surname>Bukowska</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Spiller</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Wolke</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Lendeckel</surname>, <given-names>U.</given-names>
</string-name>, <string-name>
<surname>Weinert</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Hoffmann</surname>, <given-names>J.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Goette</surname>, <given-names>A.</given-names>
</string-name> (<year>2017</year>). <article-title>Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men</article-title>. <source xml:lang="en">Experimental Biology and Medicine (Maywood, N.J.)</source>, <volume>242</volume>(<issue>14</issue>), <fpage>1412</fpage>&#x02013;<lpage>1423</lpage>. <pub-id pub-id-type="doi">10.1177/1535370217718808</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0009"><mixed-citation publication-type="journal" id="bph15207-cit-0010">
<string-name>
<surname>Cai</surname>, <given-names>H.</given-names>
</string-name> (<year>2020</year>). <article-title>Sex difference and smoking predisposition in patients with COVID&#x02010;19</article-title>. <source xml:lang="en">The Lancet Respiratory Medicine</source>, <volume>8</volume>, <elocation-id>e20</elocation-id>
<pub-id pub-id-type="doi">10.1016/S2213-2600(20)30117-X</pub-id>
<pub-id pub-id-type="pmid">32171067</pub-id></mixed-citation></ref><ref id="bph15207-bib-0010"><mixed-citation publication-type="journal" id="bph15207-cit-0011">
<string-name>
<surname>Chan</surname>, <given-names>J. F.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Poon</surname>, <given-names>V. K.</given-names>
</string-name>, <string-name>
<surname>Chan</surname>, <given-names>C. C.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>A. C.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Yuen</surname>, <given-names>K. Y.</given-names>
</string-name> (<year>2020</year>). <article-title>Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID&#x02010;19) in golden Syrian hamster model: Implications for disease pathogenesis and transmissibility</article-title>. <source xml:lang="en">Clinical Infectious Diseases</source>, <volume>26</volume>, <elocation-id>ciaa325</elocation-id>
<pub-id pub-id-type="doi">10.1093/cid/ciaa325</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0011"><mixed-citation publication-type="journal" id="bph15207-cit-0012">
<string-name>
<surname>Channappanavar</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Fett</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Mack</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Ten Eyck</surname>, <given-names>P. P.</given-names>
</string-name>, <string-name>
<surname>Meyerholz</surname>, <given-names>D. K.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Perlman</surname>, <given-names>S.</given-names>
</string-name> (<year>2017</year>). <article-title>Sex&#x02010;based differences in susceptibility to severe acute respiratory syndrome coronavirus infection</article-title>. <source xml:lang="en">Journal of Immunology</source>, <volume>198</volume>, <fpage>4046</fpage>&#x02013;<lpage>4053</lpage>.</mixed-citation></ref><ref id="bph15207-bib-0012"><mixed-citation publication-type="journal" id="bph15207-cit-0013">
<string-name>
<surname>Chappell</surname>, <given-names>M. C.</given-names>
</string-name>, <string-name>
<surname>Marshall</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<surname>Alzayadneh</surname>, <given-names>E. M.</given-names>
</string-name>, <string-name>
<surname>Shaltout</surname>, <given-names>H. A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Diz</surname>, <given-names>D. I.</given-names>
</string-name> (<year>2014</year>). <article-title>Update on the angiotensin converting enzyme 2&#x02010;angiotensin (1&#x02010;7)&#x02010;MAS receptor axis: Fetal programing, sex differences, and intracellular pathways</article-title>. <source xml:lang="en">Front Endocrinol (Lausanne)</source>, <volume>4</volume>, <fpage>201</fpage>
<pub-id pub-id-type="doi">10.3389/fendo.2013.00201</pub-id>
<pub-id pub-id-type="pmid">24409169</pub-id></mixed-citation></ref><ref id="bph15207-bib-0013"><mixed-citation publication-type="journal" id="bph15207-cit-0014">
<string-name>
<surname>Chen</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Dong</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Qu</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Gong</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Han</surname>, <given-names>Y.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Zhang</surname>, <given-names>L.</given-names>
</string-name> (<year>2020</year>). <article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study</article-title>. <source xml:lang="en">Lancet</source>, <volume>395</volume>(<issue>10223</issue>), <fpage>507</fpage>&#x02013;<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30211-7</pub-id>
<pub-id pub-id-type="pmid">32007143</pub-id></mixed-citation></ref><ref id="bph15207-bib-0014"><mixed-citation publication-type="journal" id="bph15207-cit-0015">
<string-name>
<surname>Chen</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Wu</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Yan</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>G.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Ning</surname>, <given-names>Q.</given-names>
</string-name> (<year>2020</year>). <article-title>Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study</article-title>. <source xml:lang="en">BMJ</source>, <volume>368</volume>, <fpage>m1091</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.m1091</pub-id>
<pub-id pub-id-type="pmid">32217556</pub-id></mixed-citation></ref><ref id="bph15207-bib-0015"><mixed-citation publication-type="journal" id="bph15207-cit-0016">
<string-name>
<surname>Cheng</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Y.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Wang</surname>, <given-names>G. Q.</given-names>
</string-name> (<year>2020</year>). <article-title>Organ&#x02010;protective effect of angiotensin&#x02010;converting enzyme 2 and its effect on the prognosis of COVID&#x02010;19</article-title>. <source xml:lang="en">Journal of Medical Virology</source>, <volume>92</volume>(<issue>7</issue>), <fpage>726</fpage>&#x02013;<lpage>730</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.25785</pub-id>
<pub-id pub-id-type="pmid">32221983</pub-id></mixed-citation></ref><ref id="bph15207-bib-0016"><mixed-citation publication-type="journal" id="bph15207-cit-0017">
<string-name>
<surname>Cheng</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>To</surname>, <given-names>K. K.</given-names>
</string-name>, <string-name>
<surname>Chu</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>D.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Yuen</surname>, <given-names>K. Y.</given-names>
</string-name> (<year>2015</year>). <article-title>Identification of TMPRSS2 as a susceptibility gene for severe 2009 pandemic A(H1N1) influenza and A(H7N9) influenza</article-title>. <source xml:lang="en">The Journal of Infectious Diseases</source>, <volume>212</volume>, <fpage>1214</fpage>&#x02013;<lpage>1221</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiv246</pub-id>
<pub-id pub-id-type="pmid">25904605</pub-id></mixed-citation></ref><ref id="bph15207-bib-0017"><mixed-citation publication-type="journal" id="bph15207-cit-0018">
<string-name>
<surname>Colarusso</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Terlizzi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Pinto</surname>, <given-names>A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Sorrentino</surname>, <given-names>R.</given-names>
</string-name> (<year>2020</year>). <article-title>A lesson from a saboteur: High molecular weight kininogen (HMWK) impact in COVID&#x02010;19</article-title>. <source xml:lang="en">British Journal of Pharmacology</source>. <pub-id pub-id-type="doi">10.1111/bph.15154</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0018"><mixed-citation publication-type="journal" id="bph15207-cit-0019">
<string-name>
<surname>Colucci</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Yuri Arita</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Sousa Cunha</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Seno Di Marco</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Vio</surname>, <given-names>C. P.</given-names>
</string-name>, <string-name>
<surname>Pacheco&#x02010;Silva</surname>, <given-names>A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Casarini</surname>, <given-names>D. E.</given-names>
</string-name> (<year>2011</year>). <article-title>Renin&#x02010;angiotensin system may trigger kidney damage in NOD mice</article-title>. <source xml:lang="en">Journal of the Renin&#x02010;Angiotensin&#x02010;Aldosterone System</source>, <volume>12</volume>, <fpage>15</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1177/1470320310375456</pub-id>. PMID: 20627940<pub-id pub-id-type="pmid">20627940</pub-id></mixed-citation></ref><ref id="bph15207-bib-0019"><mixed-citation publication-type="journal" id="bph15207-cit-0020">
<string-name>
<surname>Conti</surname>, <given-names>P.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Younes</surname>, <given-names>A.</given-names>
</string-name> (<year>2020</year>). <article-title>Coronavirus COV&#x02010;19/SARS&#x02010;CoV&#x02010;2 affects women less than men: clinical response to viral infection</article-title>. <source xml:lang="en">Journal of Biological Regulators and Homeostatic Agents</source>, <volume>34</volume>(<issue>2</issue>), <fpage>71</fpage>
<pub-id pub-id-type="doi">10.23812/Editorial-Conti-3</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0020"><mixed-citation publication-type="journal" id="bph15207-cit-0021">
<string-name>
<surname>Crackower</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Sarao</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Oudit</surname>, <given-names>G. Y.</given-names>
</string-name>, <string-name>
<surname>Yagil</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Kozieradzki</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Scanga</surname>, <given-names>S. E.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Penninger</surname>, <given-names>J. M.</given-names>
</string-name> (<year>2002</year>). <article-title>Angiotensin&#x02010;converting enzyme 2 is an essential regulator of heart function</article-title>. <source xml:lang="en">Nature</source>, <volume>417</volume>(<issue>6891</issue>), <fpage>822</fpage>&#x02013;<lpage>828</lpage>. <pub-id pub-id-type="doi">10.1038/nature00786</pub-id>
<pub-id pub-id-type="pmid">12075344</pub-id></mixed-citation></ref><ref id="bph15207-bib-0021"><mixed-citation publication-type="journal" id="bph15207-cit-0022">
<string-name>
<surname>Crisafulli</surname>, <given-names>A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Pagliaro</surname>, <given-names>P.</given-names>
</string-name> (<year>2020</year>). <article-title>Physical activity/inactivity and COVID&#x02010;19</article-title>. <source xml:lang="en">European Journal of Preventive Cardiology</source>, <volume>18</volume>, <elocation-id>2047487320927597</elocation-id>
<pub-id pub-id-type="doi">10.1177/2047487320927597</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0022"><mixed-citation publication-type="journal" id="bph15207-cit-0023">
<string-name>
<surname>Cutolo</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Smith</surname>, <given-names>V.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Paolino</surname>, <given-names>S.</given-names>
</string-name> (<year>2020</year>). <article-title>Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID&#x02010;19 patients. Comparisons with Autoimmunity and Vaccination</article-title>. <source xml:lang="en">Clinical and Experimental Rheumatology</source>, <volume>38</volume>, <fpage>383</fpage>&#x02013;<lpage>386</lpage>.<pub-id pub-id-type="pmid">32452350</pub-id></mixed-citation></ref><ref id="bph15207-bib-0023"><mixed-citation publication-type="journal" id="bph15207-cit-0024">
<string-name>
<surname>Dhawale</surname>, <given-names>V. S.</given-names>
</string-name>, <string-name>
<surname>Amara</surname>, <given-names>V. R.</given-names>
</string-name>, <string-name>
<surname>Karpe</surname>, <given-names>P. A.</given-names>
</string-name>, <string-name>
<surname>Malek</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Patel</surname>, <given-names>D.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Tikoo</surname>, <given-names>K.</given-names>
</string-name> (<year>2016</year>). <article-title>Activation of angiotensin&#x02010;converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model</article-title>. <source xml:lang="en">Toxicology and Applied Pharmacology</source>, <volume>306</volume>, <fpage>17</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2016.06.026</pub-id>
<pub-id pub-id-type="pmid">27343405</pub-id></mixed-citation></ref><ref id="bph15207-bib-0024"><mixed-citation publication-type="journal" id="bph15207-cit-0025">
<string-name>
<surname>Fagone</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Ciurleo</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Lombardo</surname>, <given-names>S. D.</given-names>
</string-name>, <string-name>
<surname>Iacobello</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Palermo</surname>, <given-names>C. I.</given-names>
</string-name>, <string-name>
<surname>Shoenfeld</surname>, <given-names>Y.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Nicoletti</surname>, <given-names>F.</given-names>
</string-name> (<year>2020</year>). <article-title>Transcriptional landscape of SARS&#x02010;CoV&#x02010;2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex&#x02010;specific differences and predicts tailored therapeutic strategies</article-title>. <source xml:lang="en">Autoimmunity Reviews</source>, <volume>3</volume>, <elocation-id>102571</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.autrev.2020.102571</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0025"><mixed-citation publication-type="journal" id="bph15207-cit-0026">
<string-name>
<surname>Fern&#x000e1;ndez&#x02010;Atucha</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Izagirre</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Fraile&#x02010;Berm&#x000fa;dez</surname>, <given-names>A. B.</given-names>
</string-name>, <string-name>
<surname>Kortajarena</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Larrinaga</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Martinez&#x02010;Lage</surname>, <given-names>P.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Gil</surname>, <given-names>J.</given-names>
</string-name> (<year>2017</year>). <article-title>Sex differences in the aging pattern of renin&#x02010;angiotensin system serum peptidases</article-title>. <source xml:lang="en">Biology of Sex Differences</source>, <volume>8</volume>, <fpage>5</fpage>
<pub-id pub-id-type="doi">10.1186/s13293-017-0128-8</pub-id>
<pub-id pub-id-type="pmid">28174624</pub-id></mixed-citation></ref><ref id="bph15207-bib-0026"><mixed-citation publication-type="journal" id="bph15207-cit-0027">
<string-name>
<surname>Fischinger</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Boudreau</surname>, <given-names>C. M.</given-names>
</string-name>, <string-name>
<surname>Butler</surname>, <given-names>A. L.</given-names>
</string-name>, <string-name>
<surname>Streeck</surname>, <given-names>H.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Alter</surname>, <given-names>G.</given-names>
</string-name> (<year>2019</year>). <article-title>Sex differences in vaccine&#x02010;induced humoral immunity</article-title>. <source xml:lang="en">Seminars in Immunopathology</source>, <volume>41</volume>(<issue>2</issue>), <fpage>239</fpage>&#x02013;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1007/s00281-018-0726-5</pub-id>
<pub-id pub-id-type="pmid">30547182</pub-id></mixed-citation></ref><ref id="bph15207-bib-0027"><mixed-citation publication-type="journal" id="bph15207-cit-0028">
<string-name>
<surname>Gagliardi</surname>, <given-names>M. C.</given-names>
</string-name>, <string-name>
<surname>Tieri</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Ortona</surname>, <given-names>E.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Ruggieri</surname>, <given-names>A.</given-names>
</string-name> (<year>2020</year>). <article-title>ACE2 expression and sex disparity in COVID&#x02010;19</article-title>. <source xml:lang="en">Cell Death Discov</source>, <volume>6</volume>, <fpage>37</fpage>
<pub-id pub-id-type="doi">10.1038/s41420-020-0276-1</pub-id>
<pub-id pub-id-type="pmid">32499922</pub-id></mixed-citation></ref><ref id="bph15207-bib-0028"><mixed-citation publication-type="journal" id="bph15207-cit-0029">
<string-name>
<surname>Gemmati</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Bramanti</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Serino</surname>, <given-names>M. L.</given-names>
</string-name>, <string-name>
<surname>Secchiero</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Zauli</surname>, <given-names>G.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Tisato</surname>, <given-names>V.</given-names>
</string-name> (<year>2020</year>). <article-title>COVID&#x02010;19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. Might the double X&#x02010;chromosome in females be protective against SARS&#x02010;CoV&#x02010;2 compared to the single X&#x02010;chromosome in males?</article-title>
<source xml:lang="en">International Journal of Molecular Sciences</source>, <volume>21</volume>(<issue>10</issue>), <elocation-id>E3474</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms21103474</pub-id>
<pub-id pub-id-type="pmid">32423094</pub-id></mixed-citation></ref><ref id="bph15207-bib-0029"><mixed-citation publication-type="journal" id="bph15207-cit-0030">
<string-name>
<surname>Gheblawi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Viveiros</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<surname>Turner</surname>, <given-names>A. J.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Oudit</surname>, <given-names>G. Y.</given-names>
</string-name> (<year>2020</year>). <article-title>Angiotensin converting enzyme 2: SARS&#x02010;CoV&#x02010;2 receptor and regulator of the renin&#x02010;angiotensin system</article-title>. <source xml:lang="en">Circulation Research</source>, <volume>126</volume>(<issue>10</issue>), <fpage>1456</fpage>&#x02013;<lpage>1474</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.120.317015</pub-id>
<pub-id pub-id-type="pmid">32264791</pub-id></mixed-citation></ref><ref id="bph15207-bib-0030"><mixed-citation publication-type="journal" id="bph15207-cit-0031">
<string-name>
<surname>Ghosh</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Klein</surname>, <given-names>R. S.</given-names>
</string-name> (<year>2017</year>). <article-title>Sex drives dimorphic immune responses to viral infections</article-title>. <source xml:lang="en">Journal of Immunology</source>, <volume>198</volume>(<issue>5</issue>), <fpage>1782</fpage>&#x02013;<lpage>1790</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1601166</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0031"><mixed-citation publication-type="journal" id="bph15207-cit-0032">
<string-name>
<surname>Guan</surname>, <given-names>W. J.</given-names>
</string-name>, <string-name>
<surname>Ni</surname>, <given-names>Z. Y.</given-names>
</string-name>, <string-name>
<surname>Hu</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Liang</surname>, <given-names>W. H.</given-names>
</string-name>, <string-name>
<surname>Ou</surname>, <given-names>C. Q.</given-names>
</string-name>, <string-name>
<surname>He</surname>, <given-names>J. X.</given-names>
</string-name>, &#x02026; 
<collab collab-type="authors">China Medical Treatment Expert Group for Covid&#x02010;19</collab>
. (<year>2020</year>). <article-title>Clinical characteristics of coronavirus disease 2019 in China</article-title>. <source xml:lang="en">The New England Journal of Medicine</source>, <volume>382</volume>, <fpage>1708</fpage>&#x02013;<lpage>1720</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2002032</pub-id>
<pub-id pub-id-type="pmid">32109013</pub-id></mixed-citation></ref><ref id="bph15207-bib-0032"><mixed-citation publication-type="journal" id="bph15207-cit-0033">
<string-name>
<surname>Gurwitz</surname>, <given-names>D.</given-names>
</string-name> (<year>2020</year>). <article-title>Angiotensin receptor blockers as tentative SARSCoV&#x02010;2 therapeutics</article-title>. <source xml:lang="en">Drug Development Research</source>. <pub-id pub-id-type="doi">10.1002/ddr.21656</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0033"><mixed-citation publication-type="journal" id="bph15207-cit-0034">
<string-name>
<surname>Guzik</surname>, <given-names>T. J.</given-names>
</string-name>, <string-name>
<surname>Mohiddin</surname>, <given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Dimarco</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Patel</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Savvatis</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Marelli&#x02010;Berg</surname>, <given-names>F. M.</given-names>
</string-name>, &#x02026; <string-name>
<surname>McInnes</surname>, <given-names>I. B.</given-names>
</string-name> (<year>2020</year>). <article-title>COVID&#x02010;19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options</article-title>. <source xml:lang="en">Cardiovascular Research</source>, <volume>116</volume>(<issue>10</issue>), <fpage>1666</fpage>&#x02013;<lpage>1687</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvaa106</pub-id>
<pub-id pub-id-type="pmid">32352535</pub-id></mixed-citation></ref><ref id="bph15207-bib-0034"><mixed-citation publication-type="journal" id="bph15207-cit-0035">
<string-name>
<surname>Hanff</surname>, <given-names>T. C.</given-names>
</string-name>, <string-name>
<surname>Harhay</surname>, <given-names>M. O.</given-names>
</string-name>, <string-name>
<surname>Brown</surname>, <given-names>T. S.</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>, <given-names>J. B.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Mohareb</surname>, <given-names>A. M.</given-names>
</string-name> (<year>2020</year>). <article-title>Is there an association between COVID&#x02010;19 mortality and the renin&#x02010;angiotensin system&#x02014;A call for epidemiologic investigations</article-title>. <source xml:lang="en">Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America</source>, <volume>71</volume>(<issue>15</issue>), <fpage>870</fpage>&#x02013;<lpage>874</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciaa329</pub-id>
<pub-id pub-id-type="pmid">32215613</pub-id></mixed-citation></ref><ref id="bph15207-bib-0035"><mixed-citation publication-type="journal" id="bph15207-cit-0036">
<string-name>
<surname>Harding</surname>, <given-names>S. D.</given-names>
</string-name>, <string-name>
<surname>Sharman</surname>, <given-names>J. L.</given-names>
</string-name>, <string-name>
<surname>Faccenda</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Southan</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Pawson</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<surname>Ireland</surname>, <given-names>S.</given-names>
</string-name>, &#x02026; 
<collab collab-type="authors">NC&#x02010;IUPHAR</collab>
. (<year>2018</year>). <article-title>The IUPHAR/BPS guide to PHARMACOLOGY in 2018: Updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY</article-title>. <source xml:lang="en">Nucleic Acids Research</source>, <volume>46</volume>, <fpage>D1091</fpage>&#x02013;<lpage>D1106</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx1121</pub-id>
<pub-id pub-id-type="pmid">29149325</pub-id></mixed-citation></ref><ref id="bph15207-bib-0036"><mixed-citation publication-type="journal" id="bph15207-cit-0037">
<string-name>
<surname>Hilliard</surname>, <given-names>L. M.</given-names>
</string-name>, <string-name>
<surname>Sampson</surname>, <given-names>A. K.</given-names>
</string-name>, <string-name>
<surname>Brown</surname>, <given-names>R. D.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Denton</surname>, <given-names>K. M.</given-names>
</string-name> (<year>2013</year>). <article-title>The &#x0201c;his and hers&#x0201d; of the renin&#x02010;angiotensin system</article-title>. <source xml:lang="en">Current Hypertension Reports</source>, <volume>15</volume>(<issue>1</issue>), <fpage>71</fpage>&#x02013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1007/s11906-012-0319-y</pub-id>
<pub-id pub-id-type="pmid">23180053</pub-id></mixed-citation></ref><ref id="bph15207-bib-0037"><mixed-citation publication-type="journal" id="bph15207-cit-0038">
<string-name>
<surname>Hoffmann</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Kleine&#x02010;Weber</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Schroeder</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Kr&#x000fc;ger</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Herrler</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Erichsen</surname>, <given-names>S.</given-names>
</string-name>, &#x02026; <string-name>
<surname>P&#x000f6;hlmann</surname>, <given-names>S.</given-names>
</string-name> (<year>2020</year>). <article-title>SARS&#x02010;CoV&#x02010;2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</article-title>. <source xml:lang="en">Cell</source>, <volume>181</volume>(<issue>2</issue>), <fpage>271</fpage>&#x02013;<lpage>280.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2020.02.052</pub-id>
<pub-id pub-id-type="pmid">32142651</pub-id></mixed-citation></ref><ref id="bph15207-bib-0038"><mixed-citation publication-type="journal" id="bph15207-cit-0039">
<string-name>
<surname>Horby</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Lim</surname>, <given-names>W. S.</given-names>
</string-name>, <string-name>
<surname>Emberson</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Mafham</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Bell</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Linsell</surname>, <given-names>L.</given-names>
</string-name>, &#x02026; 
<collab collab-type="authors">RECOVERY Collaborative Group</collab>
. (<year>2020</year>). <article-title>Effect of dexamethasone in hospitalized patients with COVID&#x02010;19: Preliminary report</article-title>. <source xml:lang="en">medRxiv</source>. <pub-id pub-id-type="doi">10.1101/2020.06.22.20137273</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0039"><mixed-citation publication-type="journal" id="bph15207-cit-0040">
<string-name>
<surname>Horn</surname>, <given-names>E. M.</given-names>
</string-name>, <string-name>
<surname>Chakinala</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Oudiz</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Joseloff</surname>, <given-names>E.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Rosenzweig</surname>, <given-names>E. B.</given-names>
</string-name> (<year>2020</year>). <article-title>Could pulmonary arterial hypertension patients be at a lower risk from severe COVID&#x02010;19?</article-title>
<source xml:lang="en">Pulm Circ</source>, <volume>10</volume>, <elocation-id>204589402092279</elocation-id>
<pub-id pub-id-type="doi">10.1177/2045894020922799</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0040"><mixed-citation publication-type="journal" id="bph15207-cit-0041">
<string-name>
<surname>Horstman</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Dillon</surname>, <given-names>E. L.</given-names>
</string-name>, <string-name>
<surname>Urban</surname>, <given-names>R. J.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Sheffield&#x02010;Moore</surname>, <given-names>M.</given-names>
</string-name> (<year>2012</year>). <article-title>The role of androgens and estrogens on healthy aging and longevity</article-title>. <source xml:lang="en">The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences</source>, <volume>67</volume>, <fpage>1140</fpage>&#x02013;<lpage>1152</lpage>.</mixed-citation></ref><ref id="bph15207-bib-0041"><mixed-citation publication-type="journal" id="bph15207-cit-0042">
<string-name>
<surname>Huang</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Ren</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Hu</surname>, <given-names>Y.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Cao</surname>, <given-names>B.</given-names>
</string-name> (<year>2020</year>). <article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>. <source xml:lang="en">Lancet</source>, <volume>395</volume>(<issue>10223</issue>), <fpage>497</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id>
<pub-id pub-id-type="pmid">31986264</pub-id></mixed-citation></ref><ref id="bph15207-bib-0042"><mixed-citation publication-type="journal" id="bph15207-cit-0043">
<string-name>
<surname>Iyer</surname>, <given-names>S. S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Cheng</surname>, <given-names>G.</given-names>
</string-name> (<year>2012</year>). <article-title>Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease</article-title>. <source xml:lang="en">Critical Reviews in Immunology</source>, <volume>32</volume>(<issue>1</issue>), <fpage>23</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1615/critrevimmunol.v32.i1.30</pub-id>
<pub-id pub-id-type="pmid">22428854</pub-id></mixed-citation></ref><ref id="bph15207-bib-0043"><mixed-citation publication-type="journal" id="bph15207-cit-0044">
<string-name>
<surname>Jiang</surname>, <given-names>R. D.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>M. Q.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Shan</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>, <given-names>Y. W.</given-names>
</string-name>, <string-name>
<surname>Shen</surname>, <given-names>X. R.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Shi</surname>, <given-names>Z. L.</given-names>
</string-name> (<year>2020</year>). <article-title>Pathogenesis of SARS&#x02010;CoV&#x02010;2 in transgenic mice expressing human angiotensin&#x02010;converting enzyme 2</article-title>. <source xml:lang="en">Cell</source>, <volume>21</volume>, <elocation-id>S0092&#x02010;8674(20)30622&#x02010;X</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.cell.2020.05.027</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0044"><mixed-citation publication-type="journal" id="bph15207-cit-0045">
<string-name>
<surname>Karlberg</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Chong</surname>, <given-names>D. S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Lai</surname>, <given-names>W. Y.</given-names>
</string-name> (<year>2004</year>). <article-title>Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?</article-title>
<source xml:lang="en">American Journal of Epidemiology</source>, <volume>159</volume>, <fpage>229</fpage>&#x02013;<lpage>231</lpage>.<pub-id pub-id-type="pmid">14742282</pub-id></mixed-citation></ref><ref id="bph15207-bib-0045"><mixed-citation publication-type="journal" id="bph15207-cit-0046">
<string-name>
<surname>Khan</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Benthin</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Zeno</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Albertson</surname>, <given-names>T. E.</given-names>
</string-name>, <string-name>
<surname>Boyd</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Christie</surname>, <given-names>J. D.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Lazaar</surname>, <given-names>A. L.</given-names>
</string-name> (<year>2017</year>). <article-title>A pilot clinical trial of recombinant human angiotensin&#x02010;converting enzyme 2 in acute respiratory distress syndrome</article-title>. <source xml:lang="en">Critical Care</source>, <volume>21</volume>(<issue>1</issue>), <fpage>234</fpage>
<pub-id pub-id-type="doi">10.1186/s13054-017-1823-x</pub-id>
<pub-id pub-id-type="pmid">28877748</pub-id></mixed-citation></ref><ref id="bph15207-bib-0046"><mixed-citation publication-type="journal" id="bph15207-cit-0047">
<string-name>
<surname>Kiss</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Balasubramanian</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Valcarcel&#x02010;Ares</surname>, <given-names>M. N.</given-names>
</string-name>, <string-name>
<surname>Tarantini</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Yabluchanskiy</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Csipo</surname>, <given-names>T.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Ungvari</surname>, <given-names>Z.</given-names>
</string-name> (<year>2019</year>). <article-title>Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: A potential mechanism for the prevention of vascular cognitive impairment</article-title>. <source xml:lang="en">Geroscience</source>, <volume>41</volume>(<issue>5</issue>), <fpage>619</fpage>&#x02013;<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1007/s11357-019-00074-2</pub-id>
<pub-id pub-id-type="pmid">31144244</pub-id></mixed-citation></ref><ref id="bph15207-bib-0047"><mixed-citation publication-type="journal" id="bph15207-cit-0048">
<string-name>
<surname>Klein</surname>, <given-names>S. L.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Flanagan</surname>, <given-names>K. L.</given-names>
</string-name> (<year>2016</year>). <article-title>Sex differences in immune responses</article-title>. <source xml:lang="en">Nature Reviews. Immunology</source>, <volume>16</volume>(<issue>10</issue>), <fpage>626</fpage>&#x02013;<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2016.90</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0048"><mixed-citation publication-type="journal" id="bph15207-cit-0049">
<string-name>
<surname>Klein</surname>, <given-names>S. L.</given-names>
</string-name>, <string-name>
<surname>Hodgson</surname>, <given-names>A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Robinson</surname>, <given-names>D. P.</given-names>
</string-name> (<year>2012</year>). <article-title>Mechanisms of sex disparities in influenza pathogenesis</article-title>. <source xml:lang="en">Journal of Leukocyte Biology</source>, <volume>92</volume>(<issue>1</issue>), <fpage>67</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0811427</pub-id>
<pub-id pub-id-type="pmid">22131346</pub-id></mixed-citation></ref><ref id="bph15207-bib-0049"><mixed-citation publication-type="journal" id="bph15207-cit-0050">
<string-name>
<surname>Kollias</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Kyriakoulis</surname>, <given-names>K. G.</given-names>
</string-name>, <string-name>
<surname>Dimakakos</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Poulakou</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Stergiou</surname>, <given-names>G. S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Syrigos</surname>, <given-names>K.</given-names>
</string-name> (<year>2020</year>). <article-title>Thromboembolic risk and anticoagulant therapy in COVID&#x02010;19 patients: Emerging evidence and call for action</article-title>. <source xml:lang="en">British Journal of Haematology</source>, <volume>189</volume>(<issue>5</issue>), <fpage>846</fpage>&#x02013;<lpage>847</lpage>. <pub-id pub-id-type="doi">10.1111/bjh.16727</pub-id>
<pub-id pub-id-type="pmid">32304577</pub-id></mixed-citation></ref><ref id="bph15207-bib-0050"><mixed-citation publication-type="journal" id="bph15207-cit-0051">
<string-name>
<surname>Koni</surname>, <given-names>I.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Miyamori</surname>, <given-names>I.</given-names>
</string-name> (<year>2007</year>). <article-title>Synergistic expression of angiotensin&#x02010;converting enzyme (ACE)and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio</article-title>. <source xml:lang="en">Endocrinology</source>, <volume>148</volume>, <fpage>2453</fpage>&#x02013;<lpage>2457</lpage>. <pub-id pub-id-type="doi">10.1210/en.2006-1287</pub-id>
<pub-id pub-id-type="pmid">17303661</pub-id></mixed-citation></ref><ref id="bph15207-bib-0052"><mixed-citation publication-type="journal" id="bph15207-cit-0053">
<string-name>
<surname>Kuba</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Imai</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Rao</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Gao</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Guo</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Guan</surname>, <given-names>B.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Penninger</surname>, <given-names>J. M.</given-names>
</string-name> (<year>2005</year>). <article-title>A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus&#x02010;induced lung injury</article-title>. <source xml:lang="en">Nature Medicine</source>, <volume>11</volume>(<issue>8</issue>), <fpage>875</fpage>&#x02013;<lpage>879</lpage>. <pub-id pub-id-type="doi">10.1038/nm1267</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0053"><mixed-citation publication-type="journal" id="bph15207-cit-0054">
<string-name>
<surname>Leong</surname>, <given-names>H. N.</given-names>
</string-name>, <string-name>
<surname>Earnest</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Lim</surname>, <given-names>H. H.</given-names>
</string-name>, <string-name>
<surname>Chin</surname>, <given-names>C. F.</given-names>
</string-name>, <string-name>
<surname>Tan</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Puhaindran</surname>, <given-names>M. E.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Leo</surname>, <given-names>Y. S.</given-names>
</string-name> (<year>2006</year>). <article-title>SARS in Singapore&#x02014;Predictors of disease severity</article-title>. <source xml:lang="en">Annals of the Academy of Medicine, Singapore</source>, <volume>35</volume>, <fpage>326</fpage>&#x02013;<lpage>331</lpage>.</mixed-citation></ref><ref id="bph15207-bib-0054"><mixed-citation publication-type="journal" id="bph15207-cit-0055">
<string-name>
<surname>Li</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>L.</given-names>
</string-name>, &#x00026; <string-name>
<surname>You</surname>, <given-names>R.</given-names>
</string-name> (<year>2020</year>). <article-title>Physiological and pathological regulation of ACE2, the SARS&#x02010;CoV&#x02010;2 receptor</article-title>. <source xml:lang="en">Pharmacological Research</source>, <volume>157</volume>, <elocation-id>104833</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.phrs.2020.104833</pub-id>
<pub-id pub-id-type="pmid">32302706</pub-id></mixed-citation></ref><ref id="bph15207-bib-0055"><mixed-citation publication-type="journal" id="bph15207-cit-0056">
<string-name>
<surname>Lionetti</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Tuana</surname>, <given-names>B. S.</given-names>
</string-name>, <string-name>
<surname>Casieri</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Parikh</surname>, <given-names>M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Pierce</surname>, <given-names>G. N.</given-names>
</string-name> (<year>2019</year>). <article-title>Importance of functional food compounds in cardioprotection through action on the epigenome</article-title>. <source xml:lang="en">European Heart Journal</source>, <volume>40</volume>(<issue>7</issue>), <fpage>575</fpage>&#x02013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehy597</pub-id>
<pub-id pub-id-type="pmid">30325400</pub-id></mixed-citation></ref><ref id="bph15207-bib-0056"><mixed-citation publication-type="journal" id="bph15207-cit-0057">
<string-name>
<surname>Lu</surname>, <given-names>C.&#x02010;C.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>M.&#x02010;Y.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Chang</surname>, <given-names>Y.&#x02010;L.</given-names>
</string-name> (<year>2020</year>). <article-title>Potential therapeutic agents against COVID&#x02010;19: What we know so far</article-title>. <source xml:lang="en">Journal of the Chinese Medical Association</source>, <volume>83</volume>(<issue>6</issue>), <fpage>534</fpage>&#x02013;<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1097/JCMA.0000000000000318</pub-id>
<pub-id pub-id-type="pmid">32243270</pub-id></mixed-citation></ref><ref id="bph15207-bib-0057"><mixed-citation publication-type="journal" id="bph15207-cit-0058">
<string-name>
<surname>Lukassen</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Chua</surname>, <given-names>R. L.</given-names>
</string-name>, <string-name>
<surname>Trefzer</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Kahn</surname>, <given-names>N. C.</given-names>
</string-name>, <string-name>
<surname>Schneider</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Muley</surname>, <given-names>T.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Eils</surname>, <given-names>R.</given-names>
</string-name> (<year>2020</year>). <article-title>SARS&#x02010;CoV&#x02010;2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells</article-title>. <source xml:lang="en">EMBO J 2020</source>, <volume>39</volume>(<issue>10</issue>), <elocation-id>e105114</elocation-id>
<pub-id pub-id-type="doi">10.15252/embj.20105114</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0058"><mixed-citation publication-type="journal" id="bph15207-cit-0059">
<string-name>
<surname>Luo</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Qiu</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>D.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Li</surname>, <given-names>J.</given-names>
</string-name> (<year>2020</year>). <article-title>Tocilizumab treatment in COVID&#x02010;19: A single center experience</article-title>. <source xml:lang="en">Journal of Medical Virology</source>, <volume>92</volume>(<issue>7</issue>), <fpage>814</fpage>&#x02013;<lpage>818</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.25801</pub-id>
<pub-id pub-id-type="pmid">32253759</pub-id></mixed-citation></ref><ref id="bph15207-bib-0059"><mixed-citation publication-type="journal" id="bph15207-cit-0060">
<string-name>
<surname>M&#x000e1;rquez</surname>, <given-names>E. J.</given-names>
</string-name>, <string-name>
<surname>Trowbridge</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Kuchel</surname>, <given-names>G. A.</given-names>
</string-name>, <string-name>
<surname>Banchereau</surname>, <given-names>J.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Ucar</surname>, <given-names>D.</given-names>
</string-name> (<year>2020</year>). <article-title>The lethal sex gap: COVID&#x02010;19</article-title>. <source xml:lang="en">Immunity &#x00026; Ageing</source>, <volume>17</volume>, <fpage>13</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1186/s12979-020-00183-z</pub-id>
<pub-id pub-id-type="pmid">32457811</pub-id></mixed-citation></ref><ref id="bph15207-bib-0060"><mixed-citation publication-type="journal" id="bph15207-cit-0061">
<string-name>
<surname>McCoy</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Wambier</surname>, <given-names>C. G.</given-names>
</string-name>, <string-name>
<surname>Vano&#x02010;Galvan</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Shapiro</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Sinclair</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>M&#x000fc;ller Ramos</surname>, <given-names>P.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Goren</surname>, <given-names>A.</given-names>
</string-name> (<year>2020</year>). <article-title>Racial variations in COVID&#x02010;19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti&#x02010;androgens a potential treatment for COVID&#x02010;19?</article-title>
<source xml:lang="en">Journal of Cosmetic Dermatology</source>, <volume>19</volume>, <fpage>1542</fpage>&#x02013;<lpage>1543</lpage>. <pub-id pub-id-type="doi">10.1111/jocd.13455</pub-id>
<pub-id pub-id-type="pmid">32333494</pub-id></mixed-citation></ref><ref id="bph15207-bib-0093"><mixed-citation publication-type="journal" id="bph15207-cit-0093">
<string-name>
<surname>Menachery</surname>, <given-names>V. D.</given-names>
</string-name>, <string-name>
<surname>Sch&#x000e4;fer</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Burnum&#x02010;Johnson</surname>, <given-names>K. E.</given-names>
</string-name>, <string-name>
<surname>Mitchell</surname>, <given-names>H. D.</given-names>
</string-name>, <string-name>
<surname>Eisfeld</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<surname>Walters</surname>, <given-names>K. B.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Baric</surname>, <given-names>R. S.</given-names>
</string-name> (<year>2018</year>). <article-title>MERS&#x02010;CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape</article-title>. <source xml:lang="en">Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>115</volume>(<issue>5</issue>), <fpage>E1012</fpage>&#x02013;<lpage>E1021</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1706928115</pub-id>
<pub-id pub-id-type="pmid">29339515</pub-id></mixed-citation></ref><ref id="bph15207-bib-0061"><mixed-citation publication-type="journal" id="bph15207-cit-0062">
<string-name>
<surname>Moccia</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Gerbino</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Lionetti</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Miragoli</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Munaron</surname>, <given-names>L. M.</given-names>
</string-name>, <string-name>
<surname>Pagliaro</surname>, <given-names>P.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Angelone</surname>, <given-names>T.</given-names>
</string-name> (<year>2020</year>). <article-title>COVID&#x02010;19&#x02010;associated cardiovascular morbidity in older adults: A position paper from the Italian Society of Cardiovascular Researches</article-title>. <source xml:lang="en">Geroscience</source>, <volume>42</volume>(<issue>4</issue>), <fpage>1021</fpage>&#x02013;<lpage>1049</lpage>. <pub-id pub-id-type="doi">10.1007/s11357-020-00198-w</pub-id>
<pub-id pub-id-type="pmid">32430627</pub-id></mixed-citation></ref><ref id="bph15207-bib-0062"><mixed-citation publication-type="journal" id="bph15207-cit-0063">
<string-name>
<surname>Monteil</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Kwon</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Prado</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Hagelkr&#x000fc;ys</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Wimmer</surname>, <given-names>R. A.</given-names>
</string-name>, <string-name>
<surname>Stahl</surname>, <given-names>M.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Penninger</surname>, <given-names>J. M.</given-names>
</string-name> (<year>2020</year>). <article-title>Inhibition of SARS&#x02010;CoV&#x02010;2 infections in engineered human tissues using clinical&#x02010;grade soluble human ACE2</article-title>. <source xml:lang="en">Cell</source>, <volume>181</volume>(<issue>20</issue>), <fpage>30398</fpage>&#x02013;<lpage>30399</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2020.04.004</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0063"><mixed-citation publication-type="journal" id="bph15207-cit-0064">
<string-name>
<surname>Pagliaro</surname>, <given-names>P.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Penna</surname>, <given-names>C.</given-names>
</string-name> (<year>2005</year>). <article-title>Rethinking the renin&#x02010;angiotensin system and its role in cardiovascular regulation</article-title>. <source xml:lang="en">Cardiovascular Drugs and Therapy</source>, <volume>19</volume>(<issue>1</issue>), <fpage>77</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1007/s10557-005-6900-8</pub-id>
<pub-id pub-id-type="pmid">15883759</pub-id></mixed-citation></ref><ref id="bph15207-bib-0064"><mixed-citation publication-type="journal" id="bph15207-cit-0065">
<string-name>
<surname>Pagliaro</surname>, <given-names>P.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Penna</surname>, <given-names>C.</given-names>
</string-name> (<year>2020</year>). <article-title>ACE/ACE2 ratio: A key also in 2019 coronavirus disease (Covid&#x02010;19)?</article-title>
<source xml:lang="en">Frontiers in Medicine</source>, <volume>7</volume>, <fpage>335</fpage>
<pub-id pub-id-type="doi">10.3389/fmed.2020.00335</pub-id>
<pub-id pub-id-type="pmid">32626721</pub-id></mixed-citation></ref><ref id="bph15207-bib-0065"><mixed-citation publication-type="journal" id="bph15207-cit-0066">
<string-name>
<surname>Paliani</surname>, <given-names>U.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Cardona</surname>, <given-names>A.</given-names>
</string-name> (<year>2020</year>). <article-title>COVID&#x02010;19 and hydroxychloroquine: Is the wonder drug failing?</article-title>
<source xml:lang="en">European Journal of Internal Medicine</source>, <volume>78</volume>, <fpage>1</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejim.2020.06.002</pub-id>
<pub-id pub-id-type="pmid">32553587</pub-id></mixed-citation></ref><ref id="bph15207-bib-0066"><mixed-citation publication-type="journal" id="bph15207-cit-0067">
<string-name>
<surname>Patel</surname>, <given-names>V. B.</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<surname>Grant</surname>, <given-names>M. B.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Oudit</surname>, <given-names>G. Y.</given-names>
</string-name> (<year>2016</year>). <article-title>Role of the ACE2/angiotensin 1&#x02010;7 axis of the renin&#x02010;angiotensin system in heart failure</article-title>. <source xml:lang="en">Circulation Research</source>, <volume>118</volume>, <fpage>1313</fpage>&#x02013;<lpage>1326</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.307708</pub-id>
<pub-id pub-id-type="pmid">27081112</pub-id></mixed-citation></ref><ref id="bph15207-bib-0067"><mixed-citation publication-type="journal" id="bph15207-cit-0068">
<string-name>
<surname>Pooladanda</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Thatikonda</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Bale</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Pattnaik</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Sigalapalli</surname>, <given-names>D. K.</given-names>
</string-name>, <string-name>
<surname>Bathini</surname>, <given-names>N. B.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Godugu</surname>, <given-names>C.</given-names>
</string-name> (<year>2019</year>). <article-title>Nimbolide protects against endotoxin&#x02010;induced acute respiratory distress syndrome by inhibiting TNF&#x02010;&#x003b1; mediated NF&#x02010;&#x003ba;B and HDAC&#x02010;3 nuclear translocation</article-title>. <source xml:lang="en">Cell Death &#x00026; Disease</source>, <volume>10</volume>(<issue>2</issue>), <fpage>81</fpage>
<pub-id pub-id-type="doi">10.1038/s41419-018-1247-9</pub-id>
<pub-id pub-id-type="pmid">30692512</pub-id></mixed-citation></ref><ref id="bph15207-bib-0068"><mixed-citation publication-type="journal" id="bph15207-cit-0069">
<string-name>
<surname>Qin</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Shi</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Yu</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Tao</surname>, <given-names>Y.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Xie</surname>, <given-names>M.</given-names>
</string-name> (<year>2020</year>). <article-title>Gendered effects on inflammation reaction and outcome of COVID&#x02010;19 patients in Wuhan</article-title>. <source xml:lang="en">Journal of Medical Virology</source>. <pub-id pub-id-type="doi">10.1002/jmv.26137</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0069"><mixed-citation publication-type="journal" id="bph15207-cit-0070">
<string-name>
<surname>Sakai</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Sekizuka</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Ami</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Nakajima</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Kitazawa</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Sato</surname>, <given-names>Y.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Takeda</surname>, <given-names>M.</given-names>
</string-name> (<year>2015</year>). <article-title>A mutant H3N2 influenza virus uses an alternative activation mechanism in TMPRSS2 knockout mice by loss of an oligosaccharide in the hemagglutinin stalk region</article-title>. <source xml:lang="en">Journal of Virology</source>, <volume>89</volume>, <fpage>5154</fpage>&#x02013;<lpage>5158</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00124-15</pub-id>
<pub-id pub-id-type="pmid">25673722</pub-id></mixed-citation></ref><ref id="bph15207-bib-0070"><mixed-citation publication-type="journal" id="bph15207-cit-0071">
<string-name>
<surname>Sama</surname>, <given-names>I. E.</given-names>
</string-name>, <string-name>
<surname>Ravera</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Santema</surname>, <given-names>B. T.</given-names>
</string-name>, <string-name>
<surname>van Goor</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Ter Maaten</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Cleland</surname>, <given-names>J. G. F.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Voors</surname>, <given-names>A. A.</given-names>
</string-name> (<year>2020</year>). <article-title>Circulating plasma concentrations of angiotensin&#x02010;converting enzyme 2 in men and women with heart failure and effects of renin&#x02010;angiotensin&#x02010;aldosterone inhibitors</article-title>. <source xml:lang="en">European Heart Journal</source>, <volume>41</volume>(<issue>19</issue>), <fpage>1810</fpage>&#x02013;<lpage>1817</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehaa373</pub-id>
<pub-id pub-id-type="pmid">32388565</pub-id></mixed-citation></ref><ref id="bph15207-bib-0071"><mixed-citation publication-type="journal" id="bph15207-cit-0072">
<string-name>
<surname>Santos</surname>, <given-names>S. H.</given-names>
</string-name>, <string-name>
<surname>Andrade</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Fernandes</surname>, <given-names>L. R.</given-names>
</string-name>, <string-name>
<surname>Sinisterra</surname>, <given-names>R. D.</given-names>
</string-name>, <string-name>
<surname>Sousa</surname>, <given-names>F. B.</given-names>
</string-name>, <string-name>
<surname>Feltenberger</surname>, <given-names>J. D.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Santos</surname>, <given-names>R. A.</given-names>
</string-name> (<year>2013</year>). <article-title>Oral angiotensin&#x02010;(1&#x02010;7) prevented obesity and hepatic inflammation by inhibition of resistin/TLR4/MAPK/NF&#x02010;&#x003ba;B in rats fed with high&#x02010;fat diet</article-title>. <source xml:lang="en">Peptides</source>, <volume>46</volume>, <fpage>47</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2013.05.010</pub-id>
<pub-id pub-id-type="pmid">23714175</pub-id></mixed-citation></ref><ref id="bph15207-bib-0072"><mixed-citation publication-type="journal" id="bph15207-cit-0073">
<string-name>
<surname>Setlur</surname>, <given-names>S. R.</given-names>
</string-name>, <string-name>
<surname>Mertz</surname>, <given-names>K. D.</given-names>
</string-name>, <string-name>
<surname>Hoshida</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Demichelis</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Lupien</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Perner</surname>, <given-names>S.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Rubin</surname>, <given-names>M. A.</given-names>
</string-name> (<year>2008</year>). <article-title>Estrogen&#x02010;dependent signaling in a molecularly distinct subclass of aggressive prostate cancer</article-title>. <source xml:lang="en">Journal of the National Cancer Institute</source>, <volume>100</volume>(<issue>11</issue>), <fpage>815</fpage>&#x02013;<lpage>825</lpage>. <pub-id pub-id-type="doi">10.1093/jnci/djn150</pub-id>
<pub-id pub-id-type="pmid">18505969</pub-id></mixed-citation></ref><ref id="bph15207-bib-0073"><mixed-citation publication-type="journal" id="bph15207-cit-0074">
<string-name>
<surname>Sharifi</surname>, <given-names>N.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Ryan</surname>, <given-names>C. J.</given-names>
</string-name> (<year>2020</year>). <article-title>Androgen hazards with COVID&#x02010;19</article-title>. <source xml:lang="en">Endocrine&#x02010;Related Cancer</source>, <volume>27</volume>(<issue>6</issue>), <fpage>E1</fpage>&#x02013;<lpage>E3</lpage>. <pub-id pub-id-type="doi">10.1530/ERC-20-0133</pub-id>
<pub-id pub-id-type="pmid">32302975</pub-id></mixed-citation></ref><ref id="bph15207-bib-0074"><mixed-citation publication-type="journal" id="bph15207-cit-0075">
<string-name>
<surname>Shi</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Wen</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Huang</surname>, <given-names>B.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Bu</surname>, <given-names>Z.</given-names>
</string-name> (<year>2020</year>). <article-title>Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS&#x02010;coronavirus 2</article-title>. <source xml:lang="en">Science</source>, <volume>368</volume>(<issue>6494</issue>), <fpage>1016</fpage>&#x02013;<lpage>1020</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb7015</pub-id>
<pub-id pub-id-type="pmid">32269068</pub-id></mixed-citation></ref><ref id="bph15207-bib-0075"><mixed-citation publication-type="journal" id="bph15207-cit-0076">
<string-name>
<surname>Suba</surname>, <given-names>Z.</given-names>
</string-name> (<year>2020</year>). <article-title>Prevention and therapy of COVID&#x02010;19 via exogenous estrogen treatment for both male and female patients; an opinion paper</article-title>. <source xml:lang="en">Journal of Pharmacy &#x00026; Pharmaceutical Sciences</source>, <volume>23</volume>(<issue>1</issue>), <fpage>75</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.18433/jpps31069</pub-id>
<pub-id pub-id-type="pmid">32324533</pub-id></mixed-citation></ref><ref id="bph15207-bib-0076"><mixed-citation publication-type="journal" id="bph15207-cit-0077">
<string-name>
<surname>Tang</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Bai</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Gong</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>D.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Sun</surname>, <given-names>Z.</given-names>
</string-name> (<year>2020</year>). <article-title>Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy</article-title>. <source xml:lang="en">Journal of Thrombosis and Haemostasis</source>, <volume>18</volume>(<issue>5</issue>), <fpage>1094</fpage>&#x02013;<lpage>1099</lpage>. <pub-id pub-id-type="doi">10.1111/jth.14817</pub-id>
<pub-id pub-id-type="pmid">32220112</pub-id></mixed-citation></ref><ref id="bph15207-bib-0077"><mixed-citation publication-type="journal" id="bph15207-cit-0078">
<string-name>
<surname>Tikellis</surname>, <given-names>C.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Thomas</surname>, <given-names>M. C.</given-names>
</string-name> (<year>2012</year>). <article-title>Angiotensin&#x02010;converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease</article-title>. <source xml:lang="en">International Journal of Peptide</source>, <volume>2012</volume>, <elocation-id>256294</elocation-id>
<pub-id pub-id-type="doi">10.1155/2012/256294</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0078"><mixed-citation publication-type="journal" id="bph15207-cit-0079">
<string-name>
<surname>Tomlins</surname>, <given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Rhodes</surname>, <given-names>D. R.</given-names>
</string-name>, <string-name>
<surname>Perner</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Dhanasekaran</surname>, <given-names>S. M.</given-names>
</string-name>, <string-name>
<surname>Mehra</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Sun</surname>, <given-names>X. W.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Chinnaiyan</surname>, <given-names>A. M.</given-names>
</string-name> (<year>2005</year>). <article-title>Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer</article-title>. <source xml:lang="en">Science</source>, <volume>310</volume>(<issue>5748</issue>), <fpage>644</fpage>&#x02013;<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1126/science.1117679</pub-id>
<pub-id pub-id-type="pmid">16254181</pub-id></mixed-citation></ref><ref id="bph15207-bib-0079"><mixed-citation publication-type="journal" id="bph15207-cit-0080">
<string-name>
<surname>Tukiainen</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Villani</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<surname>Yen</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Rivas</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Marshall</surname>, <given-names>J. L.</given-names>
</string-name>, <string-name>
<surname>Satija</surname>, <given-names>R.</given-names>
</string-name>, &#x02026; <string-name>
<surname>MacArthur</surname>, <given-names>D. G.</given-names>
</string-name> (<year>2017</year>). <article-title>Landscape of X chromosome inactivation across human tissues</article-title>. <source xml:lang="en">Nature</source>, <volume>550</volume>(<issue>7675</issue>), <fpage>244</fpage>&#x02013;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1038/nature24265</pub-id> Erratum in: <italic>Nature.</italic> 2018 Mar 7;555(7695):274<pub-id pub-id-type="pmid">29022598</pub-id></mixed-citation></ref><ref id="bph15207-bib-0080"><mixed-citation publication-type="journal" id="bph15207-cit-0081">
<string-name>
<surname>Wambier</surname>, <given-names>C. G.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Goren</surname>, <given-names>A.</given-names>
</string-name> (<year>2020</year>). <article-title>SARS&#x02010;COV&#x02010;2 infection is likely to be androgen mediated</article-title>. <source xml:lang="en">Journal of the American Academy of Dermatology</source>, <volume>83</volume>(<issue>1</issue>), <fpage>308</fpage>&#x02013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaad.2020.04.032</pub-id>
<pub-id pub-id-type="pmid">32283245</pub-id></mixed-citation></ref><ref id="bph15207-bib-0081"><mixed-citation publication-type="journal" id="bph15207-cit-0082">
<string-name>
<surname>Wang</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Hu</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Hu</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>J.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Peng</surname>, <given-names>Z.</given-names>
</string-name> (<year>2020</year>). <article-title>Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus&#x02010;infected pneumonia in Wuhan, China</article-title>. <source xml:lang="en">JAMA</source>, <volume>323</volume>(<issue>11</issue>), <fpage>1061</fpage>&#x02013;<lpage>1069</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2020.1585</pub-id>
<pub-id pub-id-type="pmid">32031570</pub-id></mixed-citation></ref><ref id="bph15207-bib-0082"><mixed-citation publication-type="journal" id="bph15207-cit-0083">
<string-name>
<surname>Wang</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Wu</surname>, <given-names>J.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Li</surname>, <given-names>C.</given-names>
</string-name> (<year>2016</year>). <article-title>Enalapril protects against myocardial ischemia/reperfusion injury in a swine model of cardiac arrest and resuscitation</article-title>. <source xml:lang="en">International Journal of Molecular Medicine</source>, <volume>38</volume>(<issue>5</issue>), <fpage>1463</fpage>&#x02013;<lpage>1473</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2016.2737</pub-id>
<pub-id pub-id-type="pmid">27633002</pub-id></mixed-citation></ref><ref id="bph15207-bib-0083"><mixed-citation publication-type="journal" id="bph15207-cit-0084">
<string-name>
<surname>Wang</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Gao</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Song</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Geng</surname>, <given-names>Z.</given-names>
</string-name> (<year>2015</year>). <article-title>Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure</article-title>. <source xml:lang="en">Journal of the Renin&#x02010;Angiotensin&#x02010;Aldosterone System</source>, <volume>16</volume>, <fpage>553</fpage>&#x02013;<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1177/1470320315576257</pub-id>
<pub-id pub-id-type="pmid">25869724</pub-id></mixed-citation></ref><ref id="bph15207-bib-0084"><mixed-citation publication-type="journal" id="bph15207-cit-0085">
<string-name>
<surname>Xie</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>F.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Liu</surname>, <given-names>Y.</given-names>
</string-name> (<year>2006</year>). <article-title>Age&#x02010; and gender&#x02010;related difference of ACE2 expression in rat lung</article-title>. <source xml:lang="en">Life Sciences</source>, <volume>78</volume>(<issue>19</issue>), <fpage>2166</fpage>&#x02013;<lpage>2171</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2005.09.038</pub-id> Erratum in: <italic>Life Sci</italic> 2006 Nov 25;79(26):2499<pub-id pub-id-type="pmid">16303146</pub-id></mixed-citation></ref><ref id="bph15207-bib-0085"><mixed-citation publication-type="journal" id="bph15207-cit-0086">
<string-name>
<surname>Yazdany</surname>, <given-names>J.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Kim</surname>, <given-names>A. H. J.</given-names>
</string-name> (<year>2020</year>). <article-title>Use of hydroxychloroquine and chloroquine during the COVID&#x02010;19 pandemic: What every clinician should know</article-title>. <source xml:lang="en">Annals of Internal Medicine</source>, <volume>172</volume>(<issue>11</issue>), <fpage>754</fpage>&#x02013;<lpage>755</lpage>. <pub-id pub-id-type="doi">10.7326/M20-1334</pub-id>
<pub-id pub-id-type="pmid">32232419</pub-id></mixed-citation></ref><ref id="bph15207-bib-0086"><mixed-citation publication-type="journal" id="bph15207-cit-0087">
<string-name>
<surname>Yuan</surname>, <given-names>Y. M.</given-names>
</string-name>, <string-name>
<surname>Luo</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Guo</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Ye</surname>, <given-names>R. S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Luo</surname>, <given-names>C.</given-names>
</string-name> (<year>2015</year>). <article-title>Activation of renin&#x02010;angiotensin&#x02010;aldosterone system (RAAS) in the lung of smoking&#x02010;induced pulmonary arterial hypertension (PAH) rats</article-title>. <source xml:lang="en">Journal of the Renin&#x02010;Angiotensin&#x02010;Aldosterone System</source>, <volume>16</volume>, <fpage>249</fpage>&#x02013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1177/1470320315576256</pub-id>
<pub-id pub-id-type="pmid">25795458</pub-id></mixed-citation></ref><ref id="bph15207-bib-0087"><mixed-citation publication-type="journal" id="bph15207-cit-0088">
<string-name>
<surname>Zhang</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>Z.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Zhang</surname>, <given-names>S.</given-names>
</string-name> (<year>2020</year>). <article-title>The use of anti&#x02010;inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID&#x02010;19): The perspectives of clinical immunologists from China</article-title>. <source xml:lang="en">Clinical Immunology</source>, <volume>214</volume>, <fpage>108393</fpage>
<pub-id pub-id-type="doi">10.1016/j.clim.2020.108393</pub-id>
<pub-id pub-id-type="pmid">32222466</pub-id></mixed-citation></ref><ref id="bph15207-bib-0088"><mixed-citation publication-type="journal" id="bph15207-cit-0089">
<string-name>
<surname>Zhao</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Ma</surname>, <given-names>Y.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Zuo</surname>, <given-names>W.</given-names>
</string-name> (<year>2020</year>). <article-title>Single&#x02010;cell RNA expression profiling of ACE2, the receptor of SARS&#x02010;CoV&#x02010;2</article-title>. <source xml:lang="en">bioRxiv</source>. <pub-id pub-id-type="doi">10.1101/2020.01.26.919985</pub-id>
</mixed-citation></ref><ref id="bph15207-bib-0089"><mixed-citation publication-type="journal" id="bph15207-cit-0090">
<string-name>
<surname>Zhou</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Yu</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Du</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Fan</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>Z.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Cao</surname>, <given-names>B.</given-names>
</string-name> (<year>2020</year>). <article-title>Clinical course and risk factors for mortality of adult inpatients with COVID&#x02010;19 in Wuhan, China: A retrospective cohort study</article-title>. <source xml:lang="en">Lancet</source>, <volume>395</volume>(<issue>10229</issue>), <fpage>1054</fpage>&#x02013;<lpage>1062</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30566-3</pub-id>
<pub-id pub-id-type="pmid">32171076</pub-id></mixed-citation></ref><ref id="bph15207-bib-0090"><mixed-citation publication-type="journal" id="bph15207-cit-0091">
<string-name>
<surname>Zhou</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Fang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Xu</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Ni</surname>, <given-names>W. J.</given-names>
</string-name>, <string-name>
<surname>Shen</surname>, <given-names>A. Z.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Meng</surname>, <given-names>X. M.</given-names>
</string-name> (<year>2020</year>). <article-title>Potential therapeutic targets and promising drugs for combating SARS&#x02010;CoV&#x02010;2</article-title>. <source xml:lang="en">British Journal of Pharmacology</source>, <volume>177</volume>, <fpage>3147</fpage>&#x02013;<lpage>3161</lpage>. <pub-id pub-id-type="doi">10.1111/bph.15092</pub-id>
<pub-id pub-id-type="pmid">32368792</pub-id></mixed-citation></ref><ref id="bph15207-bib-0091"><mixed-citation publication-type="journal" id="bph15207-cit-0092">
<string-name>
<surname>Zhou</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>X. L.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>X. G.</given-names>
</string-name>, <string-name>
<surname>Hu</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>W.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Shi</surname>, <given-names>Z. L.</given-names>
</string-name> (<year>2020</year>). <article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title>. <source xml:lang="en">Nature</source>, <volume>579</volume>(<issue>7798</issue>), <fpage>270</fpage>&#x02013;<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2012-7</pub-id> Epub 2020 Feb 3. PMID: 32015507; PMCID: PMC7095418<pub-id pub-id-type="pmid">32015507</pub-id></mixed-citation></ref></ref-list></back></article>